| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP5F1D ATP7B ABCC8 ABCD1 DNAH6 DNAH9 KIFC1 HSPD1 SMC6 DNAH2 ABCC5 DHX57 BTAF1 RFC4 ABCG1 MLH3 ATP2C1 ABCA6 CCT5 ATP1A1 ATP1A3 ATP12A KIF13A ATP2A2 ATP2A3 ATP2B1 | 6.46e-11 | 441 | 250 | 26 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP5F1D MYH2 ATP7B MOCS3 ABCC8 ABCD1 DNAH6 DNAH9 KIFC1 HSPD1 SMC6 DNAH2 ABCC5 DHX57 BTAF1 RFC4 ABCG1 MLH3 ATP2C1 ABCA6 CCT5 DNAH17 ATP1A1 ATP1A3 ATP12A KIF13A ATP2A2 ATP2A3 ATP2B1 | 9.11e-10 | 614 | 250 | 29 | GO:0140657 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | ATP7B ABCC8 ABCD1 ABCC5 ABCG1 ATP2C1 ABCA6 ATP1A1 ATP1A3 ATP12A ATP2A2 ATP2A3 ATP2B1 | 1.10e-09 | 109 | 250 | 13 | GO:0042626 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.21e-08 | 36 | 250 | 8 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.21e-08 | 36 | 250 | 8 | GO:0015662 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | ATP7B ABCC8 ATP2C1 ATP1A1 ATP1A3 ATP12A ATP2A2 ATP2A3 ATP2B1 | 7.45e-08 | 62 | 250 | 9 | GO:0019829 |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | ATP7B ABCC8 ABCD1 ABCC5 ABCG1 ATP2C1 ABCA6 ATP1A1 ATP1A3 ATP12A ATP2A2 ATP2A3 ATP2B1 | 4.03e-07 | 178 | 250 | 13 | GO:0015399 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP5F1D ATP7B ABCC8 ABCD1 GTPBP3 DNAH6 DNAH9 KIFC1 HSPD1 SMC6 DNAH2 ABCC5 DHX57 BTAF1 RFC4 ABCG1 MLH3 ATP2C1 ABCA6 CCT5 MTIF2 ATP1A1 ATP1A3 ATP12A KIF13A ATP2A2 ATP2A3 ATP2B1 | 5.15e-07 | 775 | 250 | 28 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP5F1D ATP7B ABCC8 ABCD1 GTPBP3 DNAH6 DNAH9 KIFC1 HSPD1 SMC6 DNAH2 ABCC5 DHX57 BTAF1 RFC4 ABCG1 MLH3 ATP2C1 ABCA6 CCT5 MTIF2 ATP1A1 ATP1A3 ATP12A KIF13A ATP2A2 ATP2A3 ATP2B1 | 2.43e-06 | 839 | 250 | 28 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP5F1D ATP7B ABCC8 ABCD1 GTPBP3 DNAH6 DNAH9 KIFC1 HSPD1 SMC6 DNAH2 ABCC5 DHX57 BTAF1 RFC4 ABCG1 MLH3 ATP2C1 ABCA6 CCT5 MTIF2 ATP1A1 ATP1A3 ATP12A KIF13A ATP2A2 ATP2A3 ATP2B1 | 2.48e-06 | 840 | 250 | 28 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP5F1D ATP7B ABCC8 ABCD1 GTPBP3 DNAH6 DNAH9 KIFC1 HSPD1 SMC6 DNAH2 ABCC5 DHX57 BTAF1 RFC4 ABCG1 MLH3 ATP2C1 ABCA6 CCT5 MTIF2 ATP1A1 ATP1A3 ATP12A KIF13A ATP2A2 ATP2A3 ATP2B1 | 2.48e-06 | 840 | 250 | 28 | GO:0016818 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 7.39e-06 | 11 | 250 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 7.39e-06 | 11 | 250 | 4 | GO:0005388 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.30e-05 | 28 | 250 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 6.29e-05 | 55 | 250 | 6 | GO:0042974 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 6.39e-05 | 18 | 250 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 7.58e-05 | 82 | 250 | 7 | GO:1990756 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ATP7B KCNV2 RYR2 ABCC8 TRPV2 CACNA1F STIM2 CCDC51 SLC5A3 ATP2C1 SLC13A5 ATP1A1 ATP1A3 ATP12A ATP2A2 ATP2A3 ATP2B1 | 8.46e-05 | 465 | 250 | 17 | GO:0046873 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 9.29e-05 | 37 | 250 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 1.92e-04 | 95 | 250 | 7 | GO:0140767 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 2.18e-04 | 10 | 250 | 3 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 2.18e-04 | 10 | 250 | 3 | GO:0005391 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.43e-04 | 70 | 250 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH2 HIP1 MAP4 SPTA1 APC2 CLIP1 MAP3K1 MPRIP SPTBN5 CYFIP1 NF1 DST ANLN ANKRD2 DIAPH2 TLN2 PLEKHH2 KIFC1 HAP1 PPP1R9A TOGARAM2 MYRIP TUBGCP6 CCDC88C CCT5 FHOD1 ATP1A1 KIF13A | 2.89e-04 | 1099 | 250 | 28 | GO:0008092 |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 2.97e-04 | 11 | 250 | 3 | GO:0008556 | |
| GeneOntologyMolecularFunction | ADP binding | 3.26e-04 | 48 | 250 | 5 | GO:0043531 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.60e-04 | 49 | 250 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 3.88e-04 | 28 | 250 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | PRAMEF5 PRAMEF1 PRAMEF2 TRIP12 STAT5B ZBTB7A PRAMEF6 PRAMEF13 PRAMEF14 | 6.01e-04 | 187 | 250 | 9 | GO:0016922 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 6.44e-04 | 151 | 250 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 6.55e-04 | 32 | 250 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.19e-04 | 118 | 250 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | mediator complex binding | 9.21e-04 | 4 | 250 | 2 | GO:0036033 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 9.26e-04 | 35 | 250 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP5F1D ATP7B KCNV2 RYR2 ABCC8 TRPV2 CACNA1F STIM2 CCDC51 SLC5A3 ATP2C1 SLC13A5 ATP1A1 ATP1A3 ATP12A ATP2A2 ATP2A3 ATP2B1 | 9.75e-04 | 627 | 250 | 18 | GO:0022890 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP7B ABCC8 ABCD1 ABCC5 SLC5A3 ABCG1 ATP2C1 ABCA6 SLC13A5 ATP1A1 ATP1A3 ATP12A ATP2A2 ATP2A3 ATP2B1 | 1.05e-03 | 477 | 250 | 15 | GO:0022804 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.27e-03 | 130 | 250 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | EPRS1 ERCC5 SLFN14 RAD1 ELAC1 NIPBL DNASE1L1 ZC3H12A DHX57 BTAF1 RFC4 NARS2 LIG3 TARS3 MLH3 PUS10 MARF1 FTSJ3 | 1.34e-03 | 645 | 250 | 18 | GO:0140640 |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 1.49e-03 | 172 | 250 | 8 | GO:0044325 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP7B ABCC8 SLC5A3 ATP2C1 SLC13A5 ATP1A1 ATP1A3 ATP12A ATP2A2 ATP2A3 ATP2B1 | 1.51e-03 | 301 | 250 | 11 | GO:0022853 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP5F1D ATP7B KCNV2 RYR2 ABCC8 TRPV2 CACNA1F STIM2 CCDC51 SLC5A3 ATP2C1 SLC13A5 ATP1A1 ATP1A3 ATP12A ATP2A2 ATP2A3 ATP2B1 | 1.84e-03 | 664 | 250 | 18 | GO:0008324 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.85e-03 | 42 | 250 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 1.89e-03 | 20 | 250 | 3 | GO:0061608 | |
| GeneOntologyMolecularFunction | RNA polymerase III type 3 promoter sequence-specific DNA binding | 2.27e-03 | 6 | 250 | 2 | GO:0001006 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.32e-03 | 227 | 250 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | actin binding | MYH2 HIP1 SPTA1 MPRIP SPTBN5 CYFIP1 DST ANLN DIAPH2 TLN2 PLEKHH2 PPP1R9A MYRIP FHOD1 | 2.99e-03 | 479 | 250 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | retinoid binding | 3.03e-03 | 48 | 250 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | steroid hormone binding | 3.15e-03 | 7 | 250 | 2 | GO:1990239 | |
| GeneOntologyMolecularFunction | RNA polymerase III cis-regulatory region sequence-specific DNA binding | 3.15e-03 | 7 | 250 | 2 | GO:0000992 | |
| GeneOntologyMolecularFunction | lipid binding | DAB2IP HIP1 MAL TNFAIP8L3 TLR6 MAP3K1 NF1 ACBD3 HSPD1 MAPKAP1 UGT1A5 FIS1 PIGU CRABP2 UGT1A4 UGT1A3 ABCG1 CHMP4A CADPS WDFY3 ATP1A1 ATP1A3 VPS13B | 3.23e-03 | 988 | 250 | 23 | GO:0008289 |
| GeneOntologyMolecularFunction | isoprenoid binding | 3.27e-03 | 49 | 250 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | DAB2IP EPRS1 HIP1 ERCC5 EXT2 STAT5B GPD1L DST ABCD1 TPST1 MTHFD1L UGT1A5 OCM2 UGT1A4 UGT1A3 ABCG1 CHMP4A OCM GUCY2D IRAK3 | 3.31e-03 | 815 | 250 | 20 | GO:0042803 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP5F1D ATP7B KCNV2 RYR2 ABCC8 TRPV2 CACNA1F STIM2 ABCC5 CCDC51 SLC5A3 ATP2C1 SLC13A5 ATP1A1 ATP1A3 ATP12A ATP2A2 ATP2A3 ATP2B1 | 3.32e-03 | 758 | 250 | 19 | GO:0015318 |
| GeneOntologyBiologicalProcess | blastocyst formation | PRAMEF5 PRAMEF1 PRAMEF2 YAP1 PRAMEF6 PRAMEF13 FOXD3 PRAMEF14 | 4.17e-06 | 78 | 246 | 8 | GO:0001825 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH2 HIP1 SPTA1 RYR2 MAP3K1 GPD1L SPTBN5 POTEE CYFIP1 NF1 ANLN DIAPH2 TLN2 PLEKHH2 CDC42BPA POTEF PPP1R9A MYRIP CDC42BPB CCDC88C ATP2C1 MTOR FHOD1 ATP1A1 POTEJ POTEI ATP2A2 NCKAP1L | 4.70e-06 | 912 | 246 | 28 | GO:0030029 |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 3.06e-05 | 31 | 246 | 5 | GO:0098974 | |
| GeneOntologyBiologicalProcess | regulation of mast cell apoptotic process | 3.26e-05 | 6 | 246 | 3 | GO:0033025 | |
| GeneOntologyBiologicalProcess | mast cell apoptotic process | 3.26e-05 | 6 | 246 | 3 | GO:0033024 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | PRAMEF5 PRAMEF1 PRAMEF2 YAP1 NIPBL PRAMEF6 PRAMEF13 PRAMEF14 | 4.61e-05 | 108 | 246 | 8 | GO:0035019 |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 5.62e-05 | 35 | 246 | 5 | GO:0099188 | |
| GeneOntologyBiologicalProcess | mast cell homeostasis | 5.66e-05 | 7 | 246 | 3 | GO:0033023 | |
| GeneOntologyBiologicalProcess | heart process | MC3R EXT2 RYR2 GPD1L YAP1 ZC3H12A THRB MTOR ATP1A1 ATP1A3 ATP2A2 ATP2A3 ATP2B1 | 9.28e-05 | 309 | 246 | 13 | GO:0003015 |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | DAB2IP GADD45B PRAMEF5 TNFAIP8L3 PAK4 RNF13 RB1CC1 TLR6 PRAMEF1 PRAMEF2 MAP3K1 NF1 KITLG SEMA6A PRAMEF6 ZC3H12A MAGED1 EPGN PRAMEF13 CCDC88C PRAMEF14 IRAK3 PIK3R5 | 1.24e-04 | 815 | 246 | 23 | GO:0043408 |
| GeneOntologyBiologicalProcess | mast cell proliferation | 1.34e-04 | 9 | 246 | 3 | GO:0070662 | |
| GeneOntologyBiologicalProcess | regulation of mast cell proliferation | 1.34e-04 | 9 | 246 | 3 | GO:0070666 | |
| GeneOntologyBiologicalProcess | MAPK cascade | DAB2IP GADD45B PRAMEF5 TNFAIP8L3 PAK4 RNF13 RB1CC1 TLR6 PRAMEF1 PRAMEF2 MAP3K1 NF1 KITLG SEMA6A PRAMEF6 ZC3H12A MAGED1 GRB10 EPGN PRAMEF13 CCDC88C PRAMEF14 IRAK3 ATP1A3 PIK3R5 | 1.34e-04 | 930 | 246 | 25 | GO:0000165 |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 1.42e-04 | 2 | 246 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | axonogenesis | RAPH1 TRIO POTEE CYFIP1 DST DRAXIN GLI3 ANAPC2 TRPV2 DIAPH2 SEMA6A PLXNB1 CACNA1F POTEF CRABP2 POTEJ POTEI EPHA10 | 1.64e-04 | 566 | 246 | 18 | GO:0007409 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH2 HIP1 SPTA1 APC2 MAP3K1 MPRIP SPTBN5 POTEE DST ANLN DIAPH2 TLN2 PLEKHH2 CDC42BPA HAP1 POTEF PPP1R9A MYRIP OCM2 CDC42BPB OCM FHOD1 POTEJ POTEI ATP12A | 3.61e-08 | 576 | 252 | 25 | GO:0015629 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.82e-07 | 93 | 252 | 10 | GO:0030864 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 3.80e-06 | 129 | 252 | 10 | GO:0030863 | |
| GeneOntologyCellularComponent | transferase complex | MED18 PRAMEF5 ATG13 EXT2 RB1CC1 PRAMEF1 PRAMEF2 PHKA1 POTEE ZBTB7A ANAPC2 BUB1B KLHL42 SGF29 MGA PRAMEF6 TBPL1 POTEF SMC6 PRAMEF13 KLHL25 PRAMEF14 ZNF335 PRKDC WDFY3 POTEJ POTEI PIK3R5 | 1.59e-05 | 963 | 252 | 28 | GO:1990234 |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 2.05e-05 | 47 | 252 | 6 | GO:0031462 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH2 DLGAP2 EPPK1 MAP4 APC2 CLIP1 RYR2 MAP3K1 POTEE DST ANKRD2 DIAPH2 DNAH6 DNAH9 KIFC1 COL6A3 CEP162 POTEF TOGARAM2 DNAH2 OCM2 TUBGCP6 CHMP4A OCM CCT5 SPHKAP DNAH17 NINL POTEJ POTEI KIF13A | 3.80e-05 | 1179 | 252 | 31 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH2 DLGAP2 EPPK1 MAP4 APC2 CLIP1 RYR2 MAP3K1 POTEE DST ANKRD2 DIAPH2 DNAH6 DNAH9 KIFC1 COL6A3 CEP162 POTEF TOGARAM2 DNAH2 OCM2 TUBGCP6 CHMP4A OCM CCT5 SPHKAP DNAH17 NINL POTEJ POTEI KIF13A | 4.32e-05 | 1187 | 252 | 31 | GO:0099081 |
| GeneOntologyCellularComponent | cell cortex | MYH2 HIP1 SPTA1 CLIP1 SPTBN5 DST ANLN PLEKHH2 POTEF PPP1R9A MYRIP OCM2 OCM EXOC4 | 1.77e-04 | 371 | 252 | 14 | GO:0005938 |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.14e-04 | 25 | 252 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | DLGAP2 EPPK1 MAP4 APC2 CLIP1 MAP3K1 POTEE DST DIAPH2 DNAH6 DNAH9 KIFC1 CEP162 POTEF TOGARAM2 DNAH2 TUBGCP6 CHMP4A CCT5 DNAH17 NINL POTEJ POTEI KIF13A | 2.40e-04 | 899 | 252 | 24 | GO:0099513 |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | PRAMEF5 PRAMEF1 PRAMEF2 ANAPC2 BUB1B KLHL42 PRAMEF6 PRAMEF13 KLHL25 PRAMEF14 | 2.63e-04 | 212 | 252 | 10 | GO:0031461 |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 3.03e-04 | 49 | 252 | 5 | GO:0090533 | |
| GeneOntologyCellularComponent | cell-cell junction | MYH2 EPPK1 ATP7B PAK4 ITGAL KIAA1210 DST UBN1 MLC1 YAP1 TLN2 CDC42BPA CDC42BPB CCDC88C FHOD1 ATP1A1 PATJ ATP2A2 | 3.17e-04 | 591 | 252 | 18 | GO:0005911 |
| GeneOntologyCellularComponent | cell leading edge | RAPH1 APC2 CLIP1 DUOX1 CYFIP1 DST KITLG TRPV2 TLN2 PLEKHH2 APBB1IP CDC42BPA PPP1R9A CDC42BPB ATP2B1 EXOC4 | 3.99e-04 | 500 | 252 | 16 | GO:0031252 |
| GeneOntologyCellularComponent | cuticular plate | 4.53e-04 | 13 | 252 | 3 | GO:0032437 | |
| GeneOntologyCellularComponent | lamellipodium | RAPH1 APC2 CYFIP1 KITLG TRPV2 PLEKHH2 APBB1IP CDC42BPA PPP1R9A CDC42BPB | 5.02e-04 | 230 | 252 | 10 | GO:0030027 |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 5.21e-04 | 55 | 252 | 5 | GO:0098533 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 5.69e-04 | 32 | 252 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 5.69e-04 | 32 | 252 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | EPRS1 MED18 PRAMEF5 APC2 PRAMEF1 PRAMEF2 POTEE ANAPC2 BUB1B KXD1 KLHL42 SGF29 PRAMEF6 MAPKAP1 TBPL1 POTEF PRAMEF13 KLHL25 CCT5 MTOR PRAMEF14 PRKDC POTEJ POTEI | 7.31e-04 | 972 | 252 | 24 | GO:0140535 |
| GeneOntologyCellularComponent | microtubule associated complex | 7.69e-04 | 161 | 252 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | anchoring junction | MYH2 EPPK1 ATP7B RPS7 PAK4 ITGAL ITGB7 MPRIP KIAA1210 CYFIP1 DST UBN1 MLC1 YAP1 TLN2 APBB1IP CDC42BPA CDC42BPB CCDC88C FHOD1 IL1RL1 ATP1A1 PATJ ATP2A2 | 7.74e-04 | 976 | 252 | 24 | GO:0070161 |
| GeneOntologyCellularComponent | microtubule | MAP4 APC2 CLIP1 DST DNAH6 DNAH9 KIFC1 CEP162 TOGARAM2 DNAH2 TUBGCP6 CHMP4A CCT5 DNAH17 NINL KIF13A | 7.93e-04 | 533 | 252 | 16 | GO:0005874 |
| GeneOntologyCellularComponent | photoreceptor inner segment membrane | 8.55e-04 | 4 | 252 | 2 | GO:0060342 | |
| GeneOntologyCellularComponent | motile cilium | PRAMEF5 PRAMEF1 PRAMEF2 FSIP2 DNAH6 DNAH9 PRAMEF6 HSPD1 DNAH2 PRAMEF13 DNAH17 ATP1A1 | 1.32e-03 | 355 | 252 | 12 | GO:0031514 |
| GeneOntologyCellularComponent | cilium | PRAMEF5 MAP4 PRAMEF1 PRAMEF2 SPTBN5 FSIP2 GLI3 CPLANE1 DNAH6 DNAH9 PRAMEF6 HSPD1 CACNA1F EVC2 CEP162 TOGARAM2 DNAH2 MYRIP PRAMEF13 GUCY2D DNAH17 ATP1A1 | 1.34e-03 | 898 | 252 | 22 | GO:0005929 |
| GeneOntologyCellularComponent | intercalated disc | 1.37e-03 | 68 | 252 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | GPI-anchor transamidase complex | 1.41e-03 | 5 | 252 | 2 | GO:0042765 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase complex | 1.41e-03 | 5 | 252 | 2 | GO:0070418 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | CYP1A1 ATG13 RNF13 EXT2 EXTL2 ERGIC2 RB1CC1 NCLN CYP39A1 PTGFRN LRIT3 RYR2 DST ABCD1 STIM2 ZC3H12A UGT1A5 PIGS PIGU UGT1A4 UGT1A3 ABCG1 SEC22C MTOR GUCY2D NECAB3 ATP2A2 ATP2A3 | 1.96e-03 | 1293 | 252 | 28 | GO:0005789 |
| GeneOntologyCellularComponent | actin filament | 2.00e-03 | 146 | 252 | 7 | GO:0005884 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 2.08e-03 | 45 | 252 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | CYP1A1 ATG13 RNF13 EXT2 EXTL2 ERGIC2 RB1CC1 NCLN CYP39A1 PTGFRN LRIT3 RYR2 DST ABCD1 STIM2 ZC3H12A UGT1A5 PIGS PIGU UGT1A4 UGT1A3 ABCG1 SEC22C MTOR GUCY2D NECAB3 ATP2A2 ATP2A3 | 2.10e-03 | 1299 | 252 | 28 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | CYP1A1 ATG13 RNF13 EXT2 EXTL2 ERGIC2 RB1CC1 NCLN CYP39A1 PTGFRN LRIT3 RYR2 DST ABCD1 STIM2 ZC3H12A UGT1A5 PIGS PIGU UGT1A4 UGT1A3 ABCG1 SEC22C MTOR GUCY2D NECAB3 ATP2A2 ATP2A3 | 2.84e-03 | 1327 | 252 | 28 | GO:0042175 |
| GeneOntologyCellularComponent | actomyosin contractile ring | 2.92e-03 | 7 | 252 | 2 | GO:0005826 | |
| GeneOntologyCellularComponent | autophagosome | 3.23e-03 | 119 | 252 | 6 | GO:0005776 | |
| Domain | ATPase_P-typ_TM_dom | 6.35e-10 | 16 | 245 | 7 | IPR023298 | |
| Domain | - | 6.35e-10 | 16 | 245 | 7 | 1.20.1110.10 | |
| Domain | Cation_ATPase_C | 1.07e-09 | 17 | 245 | 7 | PF00689 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.07e-09 | 17 | 245 | 7 | IPR006068 | |
| Domain | Cation_ATPase_N | 1.73e-09 | 18 | 245 | 7 | PF00690 | |
| Domain | Cation_ATPase_N | 1.73e-09 | 18 | 245 | 7 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.70e-09 | 19 | 245 | 7 | IPR004014 | |
| Domain | ATPase_P-typ_P_site | 1.72e-08 | 36 | 245 | 8 | IPR018303 | |
| Domain | P_typ_ATPase | 1.72e-08 | 36 | 245 | 8 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.72e-08 | 36 | 245 | 8 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.17e-08 | 37 | 245 | 8 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.17e-08 | 37 | 245 | 8 | PF00122 | |
| Domain | ARM-type_fold | HIP1 APC2 KPNA6 TRIP12 MAP3K1 URB1 NF1 DIAPH2 UTP20 NIPBL UBR4 TOGARAM2 RANBP6 BTAF1 IPO9 MTOR FHOD1 PRKDC WDFY3 | 1.22e-07 | 339 | 245 | 19 | IPR016024 |
| Domain | - | 1.56e-07 | 32 | 245 | 7 | 3.40.1110.10 | |
| Domain | - | 1.56e-07 | 32 | 245 | 7 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 3.02e-07 | 35 | 245 | 7 | IPR023299 | |
| Domain | - | APC2 KPNA6 TRIP12 NF1 UTP20 NIPBL TOGARAM2 RANBP6 BTAF1 IPO9 MTOR FHOD1 PRKDC WDFY3 | 1.46e-06 | 222 | 245 | 14 | 1.25.10.10 |
| Domain | PRAME_family | 3.73e-06 | 19 | 245 | 5 | IPR026271 | |
| Domain | EF-hand-dom_pair | SPTA1 SMOC1 RYR2 STAT5A STAT5B DUOX1 DST SPATA21 CACNA1F STIM2 OCM2 OCM ANKEF1 NINL NECAB3 | 6.28e-06 | 287 | 245 | 15 | IPR011992 |
| Domain | HAD-like_dom | 9.14e-06 | 79 | 245 | 8 | IPR023214 | |
| Domain | ARM-like | APC2 KPNA6 TRIP12 NF1 UTP20 NIPBL TOGARAM2 RANBP6 BTAF1 IPO9 MTOR FHOD1 PRKDC WDFY3 | 1.40e-05 | 270 | 245 | 14 | IPR011989 |
| Domain | - | SPTA1 SMOC1 RYR2 STAT5A STAT5B DUOX1 DST SPATA21 OCM2 OCM ANKEF1 NINL NECAB3 | 4.32e-05 | 261 | 245 | 13 | 1.10.238.10 |
| Domain | P-type_ATPase_IIC | 4.33e-05 | 6 | 245 | 3 | IPR005775 | |
| Domain | Actin_CS | 4.65e-05 | 16 | 245 | 4 | IPR004001 | |
| Domain | PH | ACAP1 RAPH1 TRIO MPRIP SPTBN5 ANLN PLEKHH2 APBB1IP CDC42BPA GRB10 CDC42BPB CADPS | 5.23e-05 | 229 | 245 | 12 | PF00169 |
| Domain | EF_HAND_2 | SPTA1 SMOC1 RYR2 DUOX1 DST SPATA21 STIM2 OCM2 OCM ANKEF1 NINL NECAB3 | 5.69e-05 | 231 | 245 | 12 | PS50222 |
| Domain | ACTINS_2 | 6.01e-05 | 17 | 245 | 4 | PS00432 | |
| Domain | Actin/actin-like_CS | 7.65e-05 | 18 | 245 | 4 | IPR020902 | |
| Domain | PH | DAB2IP ACAP1 RAPH1 TRIO MPRIP SPTBN5 ANLN PLEKHH2 APBB1IP CDC42BPA GRB10 CDC42BPB CADPS | 8.23e-05 | 278 | 245 | 13 | SM00233 |
| Domain | PH_DOMAIN | DAB2IP ACAP1 RAPH1 TRIO MPRIP SPTBN5 ANLN PLEKHH2 APBB1IP CDC42BPA GRB10 CDC42BPB CADPS | 8.53e-05 | 279 | 245 | 13 | PS50003 |
| Domain | PH_domain | DAB2IP ACAP1 RAPH1 TRIO MPRIP SPTBN5 ANLN PLEKHH2 APBB1IP CDC42BPA GRB10 CDC42BPB CADPS | 8.84e-05 | 280 | 245 | 13 | IPR001849 |
| Domain | ACTINS_ACT_LIKE | 9.59e-05 | 19 | 245 | 4 | PS01132 | |
| Domain | HEAT | 1.10e-04 | 58 | 245 | 6 | IPR000357 | |
| Domain | AAA+_ATPase | 1.21e-04 | 144 | 245 | 9 | IPR003593 | |
| Domain | AAA | 1.21e-04 | 144 | 245 | 9 | SM00382 | |
| Domain | Ank_2 | ACAP1 POTEE ANKRD2 TRPV2 PLA2G6 POTEF ANKEF1 ANKRD17 TNKS POTEJ POTEI | 1.32e-04 | 215 | 245 | 11 | PF12796 |
| Domain | KELK | 1.71e-04 | 2 | 245 | 2 | IPR031597 | |
| Domain | KELK | 1.71e-04 | 2 | 245 | 2 | PF15796 | |
| Domain | Ankyrin_rpt | ACAP1 RAPH1 POTEE ANKRD2 TRPV2 PLA2G6 POTEF ANKEF1 ANKRD17 TNKS POTEJ POTEI | 1.87e-04 | 262 | 245 | 12 | IPR002110 |
| Domain | Spectrin | 2.10e-04 | 23 | 245 | 4 | PF00435 | |
| Domain | Ank | ACAP1 POTEE ANKRD2 TRPV2 PLA2G6 POTEF ANKEF1 ANKRD17 TNKS POTEJ POTEI | 2.21e-04 | 228 | 245 | 11 | PF00023 |
| Domain | EFh | 2.45e-04 | 158 | 245 | 9 | SM00054 | |
| Domain | EF_hand_dom | SPTA1 SMOC1 RYR2 DUOX1 DST SPATA21 OCM2 OCM ANKEF1 NINL NECAB3 | 2.57e-04 | 232 | 245 | 11 | IPR002048 |
| Domain | HEAT_REPEAT | 3.12e-04 | 70 | 245 | 6 | PS50077 | |
| Domain | ABC_TRANSPORTER_2 | 4.03e-04 | 48 | 245 | 5 | PS50893 | |
| Domain | ABC_tran | 4.03e-04 | 48 | 245 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 4.44e-04 | 49 | 245 | 5 | PS00211 | |
| Domain | - | ACAP1 POTEE ANKRD2 TRPV2 PLA2G6 POTEF ANKEF1 ANKRD17 TNKS POTEJ POTEI | 4.52e-04 | 248 | 245 | 11 | 1.25.40.20 |
| Domain | ABC_transporter-like | 4.88e-04 | 50 | 245 | 5 | IPR003439 | |
| Domain | ANK | ACAP1 POTEE ANKRD2 TRPV2 PLA2G6 POTEF ANKEF1 ANKRD17 TNKS POTEJ POTEI | 5.00e-04 | 251 | 245 | 11 | SM00248 |
| Domain | P-type_ATPase_IIA | 5.10e-04 | 3 | 245 | 2 | IPR005782 | |
| Domain | Spectrin_repeat | 5.30e-04 | 29 | 245 | 4 | IPR002017 | |
| Domain | PH_dom-like | DAB2IP ACAP1 RAPH1 TRIO MPRIP SPTBN5 ANLN TLN2 PLEKHH2 APBB1IP CDC42BPA GRB10 CDC42BPB CADPS WDFY3 | 5.31e-04 | 426 | 245 | 15 | IPR011993 |
| Domain | ANK_REPEAT | ACAP1 POTEE ANKRD2 TRPV2 PLA2G6 POTEF ANKEF1 ANKRD17 TNKS POTEJ POTEI | 5.35e-04 | 253 | 245 | 11 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ACAP1 POTEE ANKRD2 TRPV2 PLA2G6 POTEF ANKEF1 ANKRD17 TNKS POTEJ POTEI | 5.53e-04 | 254 | 245 | 11 | IPR020683 |
| Domain | ANK_REP_REGION | ACAP1 POTEE ANKRD2 TRPV2 PLA2G6 POTEF ANKEF1 ANKRD17 TNKS POTEJ POTEI | 5.53e-04 | 254 | 245 | 11 | PS50297 |
| Domain | Actin | 6.88e-04 | 31 | 245 | 4 | IPR004000 | |
| Domain | Actin | 6.88e-04 | 31 | 245 | 4 | PF00022 | |
| Domain | ACTIN | 6.88e-04 | 31 | 245 | 4 | SM00268 | |
| Domain | - | DAB2IP ACAP1 RAPH1 TRIO MPRIP SPTBN5 ANLN TLN2 PLEKHH2 APBB1IP CDC42BPA GRB10 CDC42BPB CADPS | 6.89e-04 | 391 | 245 | 14 | 2.30.29.30 |
| Domain | ATPase_dyneun-rel_AAA | 7.29e-04 | 14 | 245 | 3 | IPR011704 | |
| Domain | MT | 7.29e-04 | 14 | 245 | 3 | PF12777 | |
| Domain | AAA_8 | 7.29e-04 | 14 | 245 | 3 | PF12780 | |
| Domain | AAA_5 | 7.29e-04 | 14 | 245 | 3 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.29e-04 | 14 | 245 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 7.29e-04 | 14 | 245 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 7.29e-04 | 14 | 245 | 3 | IPR013602 | |
| Domain | DHC_N2 | 7.29e-04 | 14 | 245 | 3 | PF08393 | |
| Domain | SPEC | 7.78e-04 | 32 | 245 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 7.78e-04 | 32 | 245 | 4 | IPR018159 | |
| Domain | DHC_fam | 9.03e-04 | 15 | 245 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 9.03e-04 | 15 | 245 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 9.03e-04 | 15 | 245 | 3 | IPR004273 | |
| Domain | ILWEQ | 1.01e-03 | 4 | 245 | 2 | PD011820 | |
| Domain | I_LWEQ | 1.01e-03 | 4 | 245 | 2 | PF01608 | |
| Domain | I_LWEQ | 1.01e-03 | 4 | 245 | 2 | PS50945 | |
| Domain | Myotonic_dystrophy_kinase_coil | 1.01e-03 | 4 | 245 | 2 | PD011252 | |
| Domain | ILWEQ_dom | 1.01e-03 | 4 | 245 | 2 | IPR002558 | |
| Domain | ILWEQ | 1.01e-03 | 4 | 245 | 2 | SM00307 | |
| Domain | Myotonic_dystrophy_kinase_coil | 1.01e-03 | 4 | 245 | 2 | IPR014930 | |
| Domain | - | 1.01e-03 | 4 | 245 | 2 | 1.20.1410.10 | |
| Domain | DMPK_coil | 1.01e-03 | 4 | 245 | 2 | PF08826 | |
| Domain | PBD | 1.10e-03 | 16 | 245 | 3 | SM00285 | |
| Domain | EF_HAND_1 | 1.53e-03 | 204 | 245 | 9 | PS00018 | |
| Domain | aa-tRNA-synth_II | 1.57e-03 | 18 | 245 | 3 | IPR006195 | |
| Domain | AA_TRNA_LIGASE_II | 1.57e-03 | 18 | 245 | 3 | PS50862 | |
| Domain | RasGAP_dom | 1.57e-03 | 18 | 245 | 3 | IPR001936 | |
| Domain | Parvalbumin | 1.67e-03 | 5 | 245 | 2 | IPR008080 | |
| Domain | Glyco_transf_64 | 1.67e-03 | 5 | 245 | 2 | PF09258 | |
| Domain | FATC | 1.67e-03 | 5 | 245 | 2 | PF02260 | |
| Domain | EXT_C | 1.67e-03 | 5 | 245 | 2 | IPR015338 | |
| Domain | CRIB | 2.16e-03 | 20 | 245 | 3 | PS50108 | |
| Domain | ABC_transporter_CS | 2.19e-03 | 42 | 245 | 4 | IPR017871 | |
| Domain | EF_Hand_1_Ca_BS | 2.22e-03 | 175 | 245 | 8 | IPR018247 | |
| Domain | PIK-rel_kinase_FAT | 2.48e-03 | 6 | 245 | 2 | IPR003151 | |
| Domain | FATC_dom | 2.48e-03 | 6 | 245 | 2 | IPR003152 | |
| Domain | FATC | 2.48e-03 | 6 | 245 | 2 | SM01343 | |
| Domain | - | 2.48e-03 | 6 | 245 | 2 | 3.90.1290.10 | |
| Domain | FAT | 2.48e-03 | 6 | 245 | 2 | PS51189 | |
| Domain | FATC | 2.48e-03 | 6 | 245 | 2 | PS51190 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 6.93e-07 | 55 | 191 | 8 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 9.19e-07 | 57 | 191 | 8 | MM15643 | |
| Pathway | WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER | 6.48e-05 | 32 | 191 | 5 | M39445 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 8.60e-05 | 54 | 191 | 6 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 8.60e-05 | 54 | 191 | 6 | MM15202 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | ATP7B RYR2 TRPV2 ATP2C1 ATP1A1 ATP1A3 ATP12A ATP2A2 ATP2A3 ATP2B1 | 1.43e-04 | 176 | 191 | 10 | MM15718 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | ATP5F1D EPRS1 EPPK1 PRAMEF5 MAP4 RPS7 PRAMEF1 PRAMEF2 GLI3 CPLANE1 PRAMEF6 HSPD1 TTC27 GRB10 ECH1 PRAMEF13 SLC5A3 IPO9 PRAMEF14 FHOD1 GEMIN4 ANKRD17 PRKDC ATP1A1 ATP2A2 EXOC4 | 1.06e-13 | 564 | 253 | 26 | 21565611 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 ACAT1 MAP4 RPS7 TRIP12 MPRIP URB1 CYFIP1 NF1 DST UBN1 ANLN MCM3AP UTP20 ALDH9A1 MGA NIPBL HSPD1 MTHFD1L TBPL1 UBR4 TTC27 NOL11 DHX57 RFC4 ECH1 LIG3 IPO9 CCT5 FHOD1 GEMIN4 ANKRD17 PRKDC WDFY3 ATP2A2 ATP2B1 EXOC4 FTSJ3 | 1.05e-12 | 1353 | 253 | 38 | 29467282 |
| Pubmed | ATP5F1D EPRS1 MYH2 ERCC5 RAPH1 SPTA1 RPS7 TRIP12 RYR2 POTEE DST SACS DNAH6 NIPBL HSPD1 STIM2 PCDHGB7 PTBP2 POTEF PPP1R9A UBR4 DNAH2 MYRIP ABCC5 DHX57 NARS2 NFE2L3 MARF1 IRAK3 PRKDC ATP1A1 POTEJ POTEI ATP1A3 ATP12A ATP2A2 ATP2A3 ATP2B1 | 7.00e-12 | 1442 | 253 | 38 | 35575683 | |
| Pubmed | EPRS1 ACAP1 ATP7B RPS7 KPNA6 EXT2 ERGIC2 NCLN ITGAL ITGB7 NF1 NUFIP2 ABCD1 ACBD3 KIFC1 HSPD1 MTHFD1L PIGS UBR4 FIS1 ECH1 PIGU TUBGCP6 ATP2C1 IPO9 MTOR FHOD1 MARF1 GEMIN4 ANKRD17 PRKDC ATP2B1 EXOC4 NCKAP1L | 7.06e-12 | 1168 | 253 | 34 | 19946888 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP GADD45B HIP1 EPPK1 TRIO NCLN MPRIP PPP1R26 URB1 DST UBN1 MCM3AP DIAPH2 TLN2 PLA2G6 ABCD1 FRAS1 CDC42BPA MTHFD1L UBR4 GRB10 BTAF1 CDC42BPB FBXO46 CCDC88C KLHL25 MTOR ZNF335 NINL PRKDC WDFY3 CABIN1 ATP2A3 | 7.53e-12 | 1105 | 253 | 33 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAPH1 TRIO MAP4 ATG13 RPS7 PAK4 TRIP12 MPRIP FSIP2 NF1 DST ANLN YAP1 BUB1B MAPKAP1 STIM2 CDC42BPA CEP162 POTEF GRB10 NARS2 CCDC88C IPO9 MTOR ANKRD17 PATJ KIF13A ATP2B1 EXOC4 | 9.05e-12 | 861 | 253 | 29 | 36931259 |
| Pubmed | 2.64e-11 | 29 | 253 | 8 | 15071553 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | EPRS1 TRIO MAP4 TRIP12 MPRIP UTP20 CDC42BPA DHX57 BTAF1 CDC42BPB MTOR ANKRD17 PRKDC ATP1A1 ATP2A2 | 2.84e-11 | 202 | 253 | 15 | 33005030 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EPRS1 KPNA6 EXT2 NCLN TRIP12 PTGFRN URB1 ANAPC2 NUFIP2 UTP20 ABCD1 ACBD3 MAGED1 PIGS UBR4 DNAH2 TTC27 RANBP6 BTAF1 ATP2C1 IPO9 MTOR GEMIN4 ANKRD17 PRKDC ATP1A1 ATP1A3 ATP2A2 EXOC4 | 7.65e-11 | 942 | 253 | 29 | 31073040 |
| Pubmed | EPPK1 ACAT1 MAP4 RPS7 TRIP12 URB1 NF1 DST MCM3AP NUFIP2 UTP20 NIPBL MTHFD1L UBR4 NOL11 DHX57 CCT5 MTOR GEMIN4 ANKRD17 PRKDC ATP1A1 ATP2A2 FTSJ3 | 1.08e-10 | 653 | 253 | 24 | 22586326 | |
| Pubmed | EPRS1 MAP4 URB1 HSPD1 CDC42BPA POTEF CDC42BPB PRKDC ATP1A1 POTEJ ATP1A3 ATP2A2 ATP2B1 FTSJ3 | 3.28e-10 | 202 | 253 | 14 | 24639526 | |
| Pubmed | EPRS1 C12orf56 ERGIC2 NCLN STAT5B DST ANAPC2 BUB1B DIAPH2 PLXNB1 KIFC1 MAPKAP1 FRAS1 MAGED1 DHX57 BTAF1 KLHL11 LIG3 MTIF2 MARF1 ANKRD17 PATJ EXOC4 | 5.62e-10 | 650 | 253 | 23 | 38777146 | |
| Pubmed | ATP5F1D EPRS1 EPPK1 ERGIC2 ITGAL ANAPC2 ACBD3 MAGED1 UBR4 RANBP6 NARS2 IPO9 GEMIN4 ANKRD17 PRKDC ATP2A2 ATP2A3 ATP2B1 EXOC4 | 1.38e-09 | 457 | 253 | 19 | 22190034 | |
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 1.75e-09 | 30 | 253 | 7 | 38786026 | |
| Pubmed | DAB2IP EPRS1 PRAMEF5 ERCC5 MAP4 ATG13 PAK4 PRAMEF1 PRAMEF2 TRIP12 URB1 ANLN CPLANE1 MGA PLXNB1 PRAMEF6 PTBP2 CEP162 SMC6 NOL11 PRAMEF13 PRAMEF14 ANKRD17 PATJ KIF13A CCDC171 ATP2B1 VPS13B NCKAP1L | 1.92e-09 | 1084 | 253 | 29 | 11544199 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 PAK4 TRIP12 NF1 UBN1 ANLN ANAPC2 BUB1B TLN2 NIPBL APBB1IP HSPD1 PTBP2 BTAF1 RFC4 IPO9 CCT5 FHOD1 GEMIN4 PRKDC EXOC4 | 2.31e-09 | 582 | 253 | 21 | 20467437 |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 2.41e-09 | 18 | 253 | 6 | 29731491 | |
| Pubmed | 2.41e-09 | 18 | 253 | 6 | 14675769 | ||
| Pubmed | 2.41e-09 | 18 | 253 | 6 | 23894331 | ||
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 2.41e-09 | 18 | 253 | 6 | 12890732 | |
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 3.50e-09 | 19 | 253 | 6 | 28604677 | |
| Pubmed | 4.97e-09 | 20 | 253 | 6 | 26694250 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 4.97e-09 | 20 | 253 | 6 | 21425410 | |
| Pubmed | 4.97e-09 | 20 | 253 | 6 | 16580637 | ||
| Pubmed | EPRS1 TRIO APC2 KPNA6 TRIP12 STAT5B MPRIP DST SACS TLN2 ACBD3 NIPBL NR1D2 MAGED1 UBR4 MYRIP TTC27 ABCC5 CDC42BPB NFE2L3 TARS3 CADPS MTIF2 NECAB3 TNKS PRKDC WDFY3 CCDC24 CABIN1 ATP2A2 EXOC4 | 5.84e-09 | 1285 | 253 | 31 | 35914814 | |
| Pubmed | 9.45e-09 | 22 | 253 | 6 | 31729367 | ||
| Pubmed | ATP5F1D MYH2 MC3R NCLN RYR2 CYFIP1 NF1 NIPBL TBPL1 UBR4 DNAH2 PIGU NARS2 LIG3 IPO9 CEP72 ANKRD17 IRAK3 WDFY3 POTEJ ATP2B1 | 1.15e-08 | 638 | 253 | 21 | 31182584 | |
| Pubmed | 1.27e-08 | 23 | 253 | 6 | 19480014 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 2.20e-08 | 25 | 253 | 6 | 12620990 | |
| Pubmed | 2.20e-08 | 25 | 253 | 6 | 37451217 | ||
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 2.85e-08 | 26 | 253 | 6 | 18500982 | |
| Pubmed | DAB2IP EPRS1 MAP4 TRIP12 CLIP1 STAT5B ANLN YAP1 ANAPC2 NUFIP2 TLN2 NIPBL HSPD1 GRB10 ELF1 KIF13A EXOC4 FTSJ3 | 3.78e-08 | 503 | 253 | 18 | 16964243 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 EPPK1 ACAT1 MAP4 RB1CC1 NCLN TRIP12 URB1 NF1 DST SACS UTP20 MGA NIPBL KIFC1 HSPD1 PPP1R9A NOL11 BTAF1 LIG3 CCT5 PRKDC ATP1A1 ATP2A2 ATP2B1 FTSJ3 | 3.96e-08 | 1024 | 253 | 26 | 24711643 |
| Pubmed | Stat5 expression is critical for mast cell development and survival. | 4.06e-08 | 6 | 253 | 4 | 12714518 | |
| Pubmed | 4.17e-08 | 46 | 253 | 7 | 17287250 | ||
| Pubmed | 4.60e-08 | 28 | 253 | 6 | 25089626 | ||
| Pubmed | ATP5F1D PAK4 EXT2 RB1CC1 NCLN MPRIP URB1 SACS BUB1B SEMA6A ALDH9A1 ACBD3 HSPD1 MAPKAP1 FRAS1 STIM2 MAGED1 CDC42BPA MTHFD1L UBR4 NOL11 ECH1 PIGU CDC42BPB SLC5A3 TUBGCP6 MTIF2 ATP2A2 ATP2B1 VPS13B EXOC4 FTSJ3 | 4.71e-08 | 1487 | 253 | 32 | 33957083 | |
| Pubmed | DAB2IP DLGAP2 TRIO APC2 CLIP1 MPRIP CYFIP1 NF1 DST NUFIP2 DIAPH2 TLN2 MGA NIPBL MAGED1 PPP1R9A UBR4 CDC42BPB CCDC88C MTOR SPHKAP ANKRD17 TNKS WDFY3 CABIN1 | 4.81e-08 | 963 | 253 | 25 | 28671696 | |
| Pubmed | EPRS1 MAP4 RPS7 PAK4 CYFIP1 DST NUFIP2 BUB1B HSPD1 STIM2 CDC42BPA ABCC5 CCT5 GEMIN4 ANKRD17 PRKDC ATP1A1 PATJ ATP2A2 ATP2B1 EXOC4 | 6.72e-08 | 708 | 253 | 21 | 39231216 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EPRS1 ERCC5 RAPH1 MAP4 TRIP12 CLIP1 ZBTB7A NF1 UBN1 ANLN YAP1 UTP20 TLN2 NIPBL BTAF1 TUBGCP6 FHOD1 ZNF335 ANKRD17 ELF1 PRKDC ATP2A2 | 6.79e-08 | 774 | 253 | 22 | 15302935 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | RPS7 EXT2 ERGIC2 NCLN PTGFRN CYFIP1 GLI3 NUFIP2 ABCD1 MGA TMUB2 ZNF697 HSPD1 MAGED1 PIGS SMC6 NOL11 ZNF407 ATP2C1 IPO9 FHOD1 GEMIN4 TNKS PRKDC ATP1A1 ATP2A2 ATP2B1 EXOC4 | 7.10e-08 | 1203 | 253 | 28 | 29180619 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ATP5F1D ATP7B ACAT1 MAP4 EXTL2 ERGIC2 RB1CC1 CLIP1 NF1 MCM3AP MAGED1 MTHFD1L PIGS FASTKD1 SMC6 TTC27 RANBP6 BTAF1 PIGU FBXO46 NARS2 PRKDC WDFY3 ATP12A ATP2A3 CDH16 | 7.95e-08 | 1061 | 253 | 26 | 33845483 |
| Pubmed | EPPK1 TRIO ACAT1 RPS7 KPNA6 EXT2 ERGIC2 RB1CC1 NCLN TRIP12 CYFIP1 DST ANLN RAD1 NUFIP2 ALDH9A1 NIPBL HSPD1 MAPKAP1 MTHFD1L PIGS UBR4 SYF2 CDC42BPB CCT5 CEP72 PRKDC ATP1A1 ATP2A2 | 9.54e-08 | 1297 | 253 | 29 | 33545068 | |
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 1.08e-07 | 32 | 253 | 6 | 37889087 | |
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 1.13e-07 | 17 | 253 | 5 | 23565261 | |
| Pubmed | 1.13e-07 | 17 | 253 | 5 | 37781892 | ||
| Pubmed | EPRS1 RPS7 NCLN TRIP12 HSPD1 DHX57 PRKDC ATP1A1 ATP1A3 ATP2A2 | 1.14e-07 | 144 | 253 | 10 | 35681168 | |
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 1.55e-07 | 18 | 253 | 5 | 39181896 | |
| Pubmed | 1.87e-07 | 8 | 253 | 4 | 10951186 | ||
| Pubmed | 1.90e-07 | 35 | 253 | 6 | 19389355 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 TRIO ACAT1 MAP4 RPS7 KPNA6 NCLN URB1 CYFIP1 NF1 UTP20 TLN2 NIPBL KIFC1 HSPD1 MTHFD1L UBR4 SMC6 NOL11 RFC4 LIG3 IPO9 CCT5 MTOR GEMIN4 PRKDC ATP1A1 ATP2A2 ATP2B1 FTSJ3 | 2.05e-07 | 1425 | 253 | 30 | 30948266 |
| Pubmed | EPRS1 DLGAP2 TRIO ACAT1 MAP4 SPTA1 RPS7 MPRIP GPD1L NWD2 CYFIP1 NF1 DST SACS NUFIP2 TLN2 DNAH6 HSPD1 PPP1R9A DHX57 CDC42BPB PPP2R2C TARS3 CCT5 CADPS ATP1A1 ATP1A3 ATP2A2 ATP2B1 EXOC4 | 2.24e-07 | 1431 | 253 | 30 | 37142655 | |
| Pubmed | ATP5F1D MYH2 HIP1 NCLN PTGFRN URB1 DST UBN1 BUB1B HSPD1 MAGED1 MTHFD1L PIGS UBR4 TTC27 RANBP6 DHX57 BTAF1 RFC4 LIG3 IPO9 CCT5 MTOR GEMIN4 PRKDC ATP1A1 CABIN1 ATP2A2 ATP2B1 EXOC4 | 2.56e-07 | 1440 | 253 | 30 | 30833792 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EPPK1 KPNA6 TRIP12 CYFIP1 ANLN UTP20 ALDH9A1 NIPBL MTHFD1L TBPL1 UBR4 NOL11 RFC4 NARS2 MTOR ANKRD17 PRKDC ATP1A1 ATP2A3 EXOC4 | 2.76e-07 | 704 | 253 | 20 | 29955894 |
| Pubmed | DAB2IP ATP5F1D EPRS1 DLGAP2 TRIO ACAT1 MAP4 RPS7 NCLN RYR2 NF1 NUFIP2 TLN2 ALDH9A1 HSPD1 MAPKAP1 STIM2 MAGED1 CDC42BPA UBR4 CDC42BPB ATP2C1 CCT5 CADPS SPHKAP ATP2A2 | 3.11e-07 | 1139 | 253 | 26 | 36417873 | |
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 3.80e-07 | 3 | 253 | 3 | 17101985 | |
| Pubmed | EPRS1 MAP4 NCLN MPRIP CYFIP1 HSPD1 MAPKAP1 GRB10 MTOR PRKDC ATP1A1 ATP2B1 EXOC4 | 5.68e-07 | 312 | 253 | 13 | 37120454 | |
| Pubmed | PTGFRN PPP1R26 GPD1L SACS TBC1D12 PLEKHH2 MGA STIM2 ZNF407 CDC42BPB CCDC88C ATP2C1 IPO9 CEP72 DNAH17 EXOC4 | 8.02e-07 | 493 | 253 | 16 | 15368895 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EPRS1 MYH2 EPPK1 ACAT1 PAK4 KPNA6 EXT2 RB1CC1 MPRIP CDAN1 YAP1 MAGED1 MTHFD1L TBPL1 CEP162 UBR4 TTC27 DHX57 RFC4 CDC42BPB LIG3 IPO9 GEMIN4 ATP2A2 ATP2A3 EXOC4 FTSJ3 | 8.91e-07 | 1284 | 253 | 27 | 17353931 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 9.91e-07 | 104 | 253 | 8 | 31240132 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH2 ERCC5 TRIO ATG13 PAK4 RB1CC1 MAP3K1 MPRIP PHKA1 CYFIP1 NF1 DST ANLN ANAPC2 NUFIP2 BUB1B CPLANE1 STIM2 CDC42BPA NOL11 FIS1 IRAK3 | 1.04e-06 | 910 | 253 | 22 | 36736316 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 EPPK1 MAP4 RPS7 KPNA6 PHKA1 CYFIP1 DST NUFIP2 ALDH9A1 ACBD3 HSPD1 MAGED1 UBR4 RFC4 LIG3 IPO9 CCT5 GEMIN4 ANKRD17 PRKDC ATP1A1 PATJ ATP2A2 FTSJ3 | 1.27e-06 | 1149 | 253 | 25 | 35446349 |
| Pubmed | 1.27e-06 | 187 | 253 | 10 | 26460568 | ||
| Pubmed | TRIO MAP4 APC2 POTEE DST TBC1D12 PLA2G6 COL6A3 FRAS1 POTEF CCDC88C FOXD3 CCT5 CADPS PRKDC ATP2A3 | 1.34e-06 | 513 | 253 | 16 | 25798074 | |
| Pubmed | MED18 TRIP12 CDAN1 DST UBN1 ANLN NUFIP2 BUB1B SGF29 KIFC1 CEP162 SMC6 ECH1 LIG3 IPO9 CEP72 CABIN1 EXOC4 | 1.43e-06 | 645 | 253 | 18 | 25281560 | |
| Pubmed | ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. | 1.51e-06 | 4 | 253 | 3 | 19258318 | |
| Pubmed | The nongastric H+-K+-ATPases: molecular and functional properties. | 1.51e-06 | 4 | 253 | 3 | 10362770 | |
| Pubmed | 1.51e-06 | 4 | 253 | 3 | 30679796 | ||
| Pubmed | mTORC1 phosphorylates the ULK1-mAtg13-FIP200 autophagy regulatory complex. | 1.51e-06 | 4 | 253 | 3 | 19690328 | |
| Pubmed | 1.51e-06 | 4 | 253 | 3 | 23169490 | ||
| Pubmed | 1.51e-06 | 4 | 253 | 3 | 10639163 | ||
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 1.70e-06 | 50 | 253 | 6 | 31806660 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ATP5F1D ACAT1 NCLN SPTBN5 POTEE DST GTPBP3 ACBD3 HSPD1 STIM2 MTHFD1L UBR4 FASTKD1 NOL11 RANBP6 DHX57 FIS1 CCDC51 ECH1 PIGU NARS2 CCT5 MTIF2 GEMIN4 ATP1A1 ATP2A2 VPS13B EXOC4 FTSJ3 | 1.75e-06 | 1496 | 253 | 29 | 32877691 |
| Pubmed | ATP5F1D HIP1 MAP4 MPRIP POTEE ZBTB7A URB1 CYFIP1 DST ANLN NUFIP2 UTP20 SGF29 NIPBL DNASE1L1 KIFC1 MAPKAP1 MAGED1 CDC42BPA MTHFD1L PPP1R9A NOL11 DHX57 CDC42BPB CCT5 GEMIN4 ANKRD17 PATJ ATP2A2 | 1.77e-06 | 1497 | 253 | 29 | 31527615 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ACAT1 MAP4 PAK4 TRIP12 MPRIP URB1 NUFIP2 MGA MAGED1 SMC6 NOL11 DHX57 CDC42BPB CCT5 MARF1 ANKRD17 ATP1A1 ATP2A2 EXOC4 | 1.79e-06 | 724 | 253 | 19 | 36232890 |
| Pubmed | ATP5F1D ERGIC2 NCLN NF1 MGA PIGS UBR4 TTC27 RANBP6 BTAF1 PIGU IPO9 MTOR GEMIN4 PRKDC ATP1A1 ATP2A2 EXOC4 | 1.85e-06 | 657 | 253 | 18 | 36180527 | |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 1.86e-06 | 195 | 253 | 10 | 17110338 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.03e-06 | 197 | 253 | 10 | 20811636 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EPRS1 ACAT1 MAP4 RPS7 TRIP12 CYFIP1 UBN1 ANLN NUFIP2 MGA NIPBL KIFC1 HSPD1 PTBP2 SMC6 NOL11 RFC4 LIG3 MARF1 PRKDC ATP2A2 FTSJ3 | 2.24e-06 | 954 | 253 | 22 | 36373674 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TRIO PHKA1 CDAN1 NWD2 NF1 NUFIP2 TLN2 MAGED1 UBR4 DHX57 TUBGCP6 CCT5 CADPS MTIF2 TNKS | 2.49e-06 | 475 | 253 | 15 | 31040226 |
| Pubmed | TBC1D19 EPRS1 RB1CC1 DST ANLN NIPBL HSPD1 PPP1R9A BTAF1 RFC4 CDC42BPB LIG3 PRKDC | 2.77e-06 | 360 | 253 | 13 | 33111431 | |
| Pubmed | SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption. | 2.92e-06 | 120 | 253 | 8 | 37929963 | |
| Pubmed | DAB2IP TRIO MPRIP CYFIP1 DST SEMA6A ACBD3 MAPKAP1 STIM2 PPP1R9A ECH1 ATP1A1 ATP2B1 EXOC4 | 2.99e-06 | 421 | 253 | 14 | 36976175 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | PRAMEF5 RB1CC1 PRAMEF1 PRAMEF2 DST MGA PRAMEF6 COL6A3 PRAMEF13 PRAMEF14 ZNF335 CABIN1 ATP2B1 | 3.04e-06 | 363 | 253 | 13 | 14691545 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | EPRS1 EPPK1 RAPH1 MAP4 ANLN NUFIP2 BUB1B KIFC1 ANKRD17 PRKDC ATP1A1 | 3.17e-06 | 256 | 253 | 11 | 33397691 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ATP7B KPNA6 SMOC1 NCLN URB1 UTP20 ALDH9A1 PIGS FASTKD1 TTC27 CCDC51 NARS2 ATP2C1 CEP72 MTOR MTIF2 NINL ATP2B1 FTSJ3 | 3.21e-06 | 754 | 253 | 19 | 33060197 |
| Pubmed | Huntingtin functions as a scaffold for selective macroautophagy. | 3.50e-06 | 15 | 253 | 4 | 25686248 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 3.50e-06 | 15 | 253 | 4 | 16824795 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.52e-06 | 123 | 253 | 8 | 26912792 | |
| Pubmed | Multiple genes encode the human Na+,K+-ATPase catalytic subunit. | 3.76e-06 | 5 | 253 | 3 | 3035563 | |
| Pubmed | Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. | 3.76e-06 | 5 | 253 | 3 | 19211835 | |
| Pubmed | 3.76e-06 | 5 | 253 | 3 | 26603207 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TBC1D19 TRIO MAP4 ATG13 STAT5B ZBTB7A ABCC8 PLA2G6 SEMA6A CDC42BPA PTBP2 PPP1R9A MYRIP GRB10 BTAF1 ECH1 CDC42BPB PPP2R2C ABCG1 ATP2C1 THRB ANKRD17 PATJ ATP2B1 ZRANB1 GPA33 VPS13B EXOC4 | 4.73e-06 | 1489 | 253 | 28 | 28611215 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | DAB2IP PAK4 NF1 SEMA6A PLXNB1 MAPKAP1 STIM2 CDC42BPA PPP1R9A ABCC5 CDC42BPB MTOR ATP1A1 PATJ ATP2B1 VPS13B | 5.04e-06 | 569 | 253 | 16 | 30639242 |
| Pubmed | EPRS1 RPS7 KPNA6 CYFIP1 ACBD3 HSPD1 PTBP2 UBR4 NOL11 IPO9 CCT5 MTOR GEMIN4 PRKDC ATP1A1 ATP2A2 EXOC4 | 5.18e-06 | 638 | 253 | 17 | 33239621 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 RAPH1 MAP4 PAK4 MPRIP DST NUFIP2 BUB1B ACBD3 NIPBL HSPD1 BTAF1 RFC4 ECH1 CRABP2 LIG3 FHOD1 ANKRD17 PRKDC ATP1A1 FTSJ3 | 5.66e-06 | 934 | 253 | 21 | 33916271 |
| Pubmed | PAK4 CLIP1 NF1 DST YAP1 MAGED1 CEP162 PPP1R9A ECH1 CCDC88C CEP72 NINL PRKDC PATJ | 5.78e-06 | 446 | 253 | 14 | 24255178 | |
| Pubmed | DLGAP2 ACAP1 MAP4 URB1 CACNA1F MYRIP GRB10 LIG3 GUCY2D SNAPC3 KIF13A ATP2A3 | 6.08e-06 | 329 | 253 | 12 | 17474147 | |
| Pubmed | ATP5F1D ACAT1 RYR2 FSIP2 DST CPLANE1 HSPD1 FIS1 ECH1 ATP1A1 ATP2A2 VPS13B | 6.46e-06 | 331 | 253 | 12 | 29199018 | |
| Pubmed | STAT5A STAT5B MPRIP ZBTB7A DST UBN1 YAP1 GLI3 SGF29 MGA NIPBL KIFC1 HSPD1 MAGED1 CDC42BPA UBR4 ECH1 LIG3 CCT5 MARF1 ANKRD17 ELF1 ATP1A1 CABIN1 ATP2A2 EXOC4 FTSJ3 | 6.49e-06 | 1429 | 253 | 27 | 35140242 | |
| Interaction | GPR17 interactions | GPD1L URB1 SACS UTP20 FASTKD1 RANBP6 BTAF1 PIGU SLC5A3 MTOR GEMIN4 PRKDC WDFY3 ATP1A3 ATP12A ATP2A2 ATP2A3 EXOC4 | 1.34e-08 | 283 | 246 | 18 | int:GPR17 |
| Interaction | LRRC31 interactions | EPRS1 TRIO MAP4 TRIP12 MPRIP UTP20 CDC42BPA DHX57 BTAF1 CDC42BPB MTOR ANKRD17 PRKDC ATP1A1 ATP2A2 | 3.56e-08 | 205 | 246 | 15 | int:LRRC31 |
| Interaction | CD80 interactions | 5.09e-07 | 79 | 246 | 9 | int:CD80 | |
| Interaction | TACSTD2 interactions | GPD1L URB1 NF1 SACS ANLN FASTKD1 RANBP6 NARS2 MTOR GEMIN4 WDFY3 | 5.37e-07 | 129 | 246 | 11 | int:TACSTD2 |
| Interaction | GPR182 interactions | ERGIC2 NCLN URB1 UTP20 ABCD1 TMUB2 FASTKD1 TTC27 BTAF1 NARS2 SLC5A3 ATP2C1 MTOR PRKDC WDFY3 ATP1A3 ATP12A ATP2A3 ATP2B1 EXOC4 | 8.76e-07 | 455 | 246 | 20 | int:GPR182 |
| Interaction | TOP3B interactions | DAB2IP GADD45B EPRS1 HIP1 EPPK1 TRIO NCLN MPRIP PPP1R26 URB1 DST UBN1 MCM3AP NUFIP2 DIAPH2 TLN2 PLA2G6 ABCD1 FRAS1 CDC42BPA MTHFD1L PPP1R9A UBR4 GRB10 DHX57 BTAF1 CDC42BPB FBXO46 CCDC88C LIG3 KLHL25 MTOR ZNF335 NINL ANKRD17 PRKDC WDFY3 CABIN1 ATP2A3 EXOC4 | 1.40e-06 | 1470 | 246 | 40 | int:TOP3B |
| Interaction | SIRT7 interactions | EPPK1 ACAT1 MAP4 RPS7 TRIP12 URB1 NF1 DST MCM3AP NUFIP2 UTP20 NIPBL MAGED1 MTHFD1L UBR4 NOL11 DHX57 CCT5 MTOR GEMIN4 ANKRD17 PRKDC ATP1A1 ATP2A2 ZRANB1 FTSJ3 | 1.56e-06 | 744 | 246 | 26 | int:SIRT7 |
| Interaction | LMBR1L interactions | EPRS1 KPNA6 EXT2 NCLN TRIP12 PTGFRN URB1 ANAPC2 NUFIP2 UTP20 ABCD1 ACBD3 EVC2 MAGED1 PIGS UBR4 DNAH2 TTC27 RANBP6 BTAF1 ATP2C1 IPO9 MTOR GEMIN4 ANKRD17 PRKDC ATP1A1 ATP1A3 ATP2A2 EXOC4 | 1.73e-06 | 946 | 246 | 30 | int:LMBR1L |
| Interaction | F2RL1 interactions | NCLN ABCC8 FASTKD1 BTAF1 PIGU ATP2C1 GEMIN4 ATP1A3 ATP12A ATP2A2 ATP2A3 ATP2B1 | 2.55e-06 | 182 | 246 | 12 | int:F2RL1 |
| Interaction | GPR173 interactions | 2.72e-06 | 51 | 246 | 7 | int:GPR173 | |
| Interaction | RHOF interactions | HIP1 EPPK1 PAK4 NCLN MPRIP POTEE CYFIP1 DIAPH2 UTP20 ACBD3 MAPKAP1 STIM2 CDC42BPA PIGS PPP1R9A ABCC5 CDC42BPB LIG3 MTOR PRKDC ATP1A1 ATP2A2 ATP2B1 VPS13B | 2.84e-06 | 673 | 246 | 24 | int:RHOF |
| Interaction | EMC2 interactions | EPRS1 MAP4 EXTL2 ERGIC2 RB1CC1 NCLN MCM3AP HSPD1 MAPKAP1 EVC2 FIS1 LIG3 ATP2C1 PRKDC ATP1A1 ATP2A2 ATP2B1 ZRANB1 | 3.30e-06 | 411 | 246 | 18 | int:EMC2 |
| Interaction | RHOA interactions | EPPK1 TRIO ERGIC2 NCLN CLIP1 MAP3K1 MPRIP CYFIP1 NF1 ANLN DIAPH2 UTP20 ABCD1 ACBD3 PLXNB1 STIM2 CDC42BPA PIGS PPP1R9A ABCC5 PIGU CDC42BPB CCDC88C ATP2C1 IPO9 MARF1 GEMIN4 PRKDC ATP1A1 PATJ ATP2A2 ATP2B1 ZRANB1 VPS13B | 3.99e-06 | 1199 | 246 | 34 | int:RHOA |
| Interaction | LGR4 interactions | EPRS1 MAP4 URB1 HSPD1 CDC42BPA POTEF CDC42BPB PRKDC ATP1A1 POTEJ ATP1A3 ATP2A2 ATP2B1 FTSJ3 | 4.46e-06 | 262 | 246 | 14 | int:LGR4 |
| Interaction | KCNA3 interactions | EPRS1 EPPK1 MAP4 RPS7 PAK4 CLIP1 MPRIP CYFIP1 DST NUFIP2 BUB1B TLN2 HSPD1 STIM2 CDC42BPA GRB10 ABCC5 CCDC88C CCT5 GEMIN4 ANKRD17 PRKDC ATP1A1 PATJ ATP2A2 ATP2B1 EXOC4 | 8.95e-06 | 871 | 246 | 27 | int:KCNA3 |
| Interaction | NUP43 interactions | ERCC5 MAP4 TRIP12 RYR2 FSIP2 DST MCM3AP BUB1B UTP20 MGA DNAH9 NIPBL NR1D2 HSPD1 NOL11 LIG3 CCT5 GUCY2D MARF1 ELF1 ZRANB1 FTSJ3 | 9.22e-06 | 625 | 246 | 22 | int:NUP43 |
| Interaction | YWHAG interactions | DAB2IP RAPH1 ATG13 RPS7 PAK4 RB1CC1 TRIP12 MAP3K1 MPRIP CYFIP1 NF1 DST ANLN YAP1 NUFIP2 HSPD1 MAPKAP1 STIM2 CDC42BPA CEP162 POTEF GRB10 ECH1 NARS2 CCDC88C IPO9 MTOR NINL ANKRD17 PRKDC PATJ KIF13A ZRANB1 EXOC4 | 9.37e-06 | 1248 | 246 | 34 | int:YWHAG |
| Interaction | YWHAZ interactions | DAB2IP RAPH1 ATG13 SPTA1 PAK4 RB1CC1 TRIP12 CLIP1 MAP3K1 MPRIP FSIP2 CYFIP1 NF1 DST ANLN YAP1 ALDH9A1 MAPKAP1 STIM2 CDC42BPA CEP162 POTEF NOL11 GRB10 CCDC88C IPO9 MTOR FHOD1 ANKRD17 WDFY3 ATP1A1 ATP2A2 RUNDC1 ATP2B1 ZRANB1 | 1.20e-05 | 1319 | 246 | 35 | int:YWHAZ |
| Interaction | P2RY8 interactions | FASTKD1 TTC27 BTAF1 PIGU ATP2C1 MTOR GEMIN4 ATP1A3 ATP12A ATP2A3 ATP2B1 | 1.31e-05 | 179 | 246 | 11 | int:P2RY8 |
| Interaction | FPR1 interactions | ERGIC2 URB1 FASTKD1 BTAF1 MTOR GEMIN4 PRKDC WDFY3 ATP12A PIK3R5 | 1.35e-05 | 147 | 246 | 10 | int:FPR1 |
| Interaction | MGARP interactions | MOCS3 MCM3AP ABCD1 FASTKD1 TTC27 BTAF1 ATP2C1 GEMIN4 PRKDC WDFY3 ATP1A3 ATP12A | 1.93e-05 | 222 | 246 | 12 | int:MGARP |
| Interaction | GPR45 interactions | ERGIC2 GPD1L MCM3AP GTPBP3 FASTKD1 BTAF1 PIGU SLC5A3 ATP2C1 MTOR GEMIN4 WDFY3 ATP1A3 ATP2A3 | 2.07e-05 | 300 | 246 | 14 | int:GPR45 |
| Interaction | TPST2 interactions | 2.18e-05 | 124 | 246 | 9 | int:TPST2 | |
| Interaction | TTC3 interactions | 2.18e-05 | 124 | 246 | 9 | int:TTC3 | |
| Interaction | RAC2 interactions | DAB2IP PAK4 NCLN POTEE CYFIP1 DST DIAPH2 UTP20 TLN2 ACBD3 STIM2 CDC42BPA PIGS PPP1R9A ABCC5 PIGU CDC42BPB MTOR FHOD1 ATP1A1 ATP2B1 VPS13B | 2.93e-05 | 674 | 246 | 22 | int:RAC2 |
| Interaction | CLEC2D interactions | ATP7B POTEE ADGRF1 FASTKD1 NARS2 ATP2C1 IL1RL1 ATP1A3 ATP12A ATP2A3 ATP2B1 | 3.19e-05 | 197 | 246 | 11 | int:CLEC2D |
| Interaction | GPR88 interactions | 3.51e-05 | 16 | 246 | 4 | int:GPR88 | |
| Interaction | COMTD1 interactions | EPRS1 PHKA1 BUB1B RANBP6 BTAF1 TARS3 IPO9 MTOR GEMIN4 ZRANB1 EXOC4 | 3.67e-05 | 200 | 246 | 11 | int:COMTD1 |
| Interaction | S1PR4 interactions | 4.80e-05 | 137 | 246 | 9 | int:S1PR4 | |
| Interaction | IL2RA interactions | 4.92e-05 | 54 | 246 | 6 | int:IL2RA | |
| Interaction | NRAS interactions | DAB2IP SPTA1 PAK4 CYFIP1 NF1 ANLN TRPV2 SEMA6A MAPKAP1 CDC42BPA PPP1R9A ABCC5 PIGU CDC42BPB SLC5A3 THRB MTOR FHOD1 ATP1A1 ATP2B1 VPS13B EXOC4 | 5.05e-05 | 699 | 246 | 22 | int:NRAS |
| Interaction | CDC5L interactions | EPPK1 ERCC5 TRIO PAK4 NF1 DST UBN1 ANLN ANAPC2 BUB1B TLN2 NIPBL HSPD1 PTBP2 BTAF1 SYF2 RFC4 IPO9 CCT5 FHOD1 GEMIN4 PRKDC ZRANB1 EXOC4 FTSJ3 | 5.11e-05 | 855 | 246 | 25 | int:CDC5L |
| Interaction | OPALIN interactions | NF1 UTP20 FASTKD1 TTC27 BTAF1 ATP2C1 MTOR PRKDC WDFY3 ATP1A3 ATP2B1 | 5.47e-05 | 209 | 246 | 11 | int:OPALIN |
| Interaction | CCDC8 interactions | EPRS1 EPPK1 MAP4 RB1CC1 NCLN TRIP12 NF1 DST SACS UTP20 NIPBL KIFC1 HSPD1 PPP1R9A BTAF1 LIG3 PRKDC ATP1A1 ATP2A2 ATP2B1 ZRANB1 | 5.91e-05 | 656 | 246 | 21 | int:CCDC8 |
| Interaction | NR3C1 interactions | ATP5F1D MYH2 MC3R NCLN RYR2 STAT5A STAT5B CYFIP1 NF1 ANLN NIPBL HSPD1 TBPL1 UBR4 DNAH2 PIGU NARS2 LIG3 IPO9 CEP72 ANKRD17 IRAK3 PRKDC WDFY3 ATP1A1 POTEJ ATP2B1 | 6.28e-05 | 974 | 246 | 27 | int:NR3C1 |
| Interaction | GAN interactions | SPTA1 SPTBN5 DST ANLN GTPBP3 DNAH6 HSPD1 COL6A3 POTEF CCT5 CEP72 NINL | 6.91e-05 | 253 | 246 | 12 | int:GAN |
| Interaction | S1PR1 interactions | 7.02e-05 | 112 | 246 | 8 | int:S1PR1 | |
| Interaction | C3orf18 interactions | 8.46e-05 | 115 | 246 | 8 | int:C3orf18 | |
| Interaction | CCDC185 interactions | 8.98e-05 | 60 | 246 | 6 | int:CCDC185 | |
| Interaction | RHOB interactions | DAB2IP HIP1 EPPK1 RAPH1 TRIO ACAT1 PAK4 NCLN MPRIP CYFIP1 NF1 ANLN DIAPH2 UTP20 STIM2 CDC42BPA PPP1R9A ABCC5 CDC42BPB SLC5A3 CCDC88C ATP1A1 PATJ ATP2B1 | 1.04e-04 | 840 | 246 | 24 | int:RHOB |
| Interaction | MLNR interactions | 1.81e-04 | 68 | 246 | 6 | int:MLNR | |
| Interaction | IQCB1 interactions | EPRS1 ANAPC2 CEP162 GRB10 ECH1 SLC5A3 IPO9 GEMIN4 ANKRD17 PRKDC ATP1A1 ATP2A2 ZRANB1 EXOC4 | 1.94e-04 | 370 | 246 | 14 | int:IQCB1 |
| Interaction | YWHAH interactions | DAB2IP EPPK1 TRIO ATG13 PAK4 RB1CC1 TRIP12 MPRIP CYFIP1 NF1 DST ANLN YAP1 MAPKAP1 STIM2 EVC2 CDC42BPA CEP162 POTEF GRB10 CCDC88C IPO9 MTOR NINL ANKRD17 PATJ ZRANB1 EXOC4 | 1.99e-04 | 1102 | 246 | 28 | int:YWHAH |
| Cytoband | 1p36.21 | 1.38e-06 | 63 | 253 | 6 | 1p36.21 | |
| Cytoband | 2q37 | 2.52e-05 | 31 | 253 | 4 | 2q37 | |
| Cytoband | 17p13.1 | 5.19e-05 | 118 | 253 | 6 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 1.44e-04 | 346 | 253 | 9 | chr17p13 | |
| Cytoband | 3q12.1 | 2.04e-04 | 21 | 253 | 3 | 3q12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q11 | 2.29e-04 | 54 | 253 | 4 | chr3q11 | |
| Cytoband | 2q21.1 | 3.02e-04 | 58 | 253 | 4 | 2q21.1 | |
| Cytoband | 8q11 | 4.47e-04 | 6 | 253 | 2 | 8q11 | |
| Cytoband | 5p13.2 | 6.63e-04 | 31 | 253 | 3 | 5p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | PRAMEF5 PRAMEF1 PRAMEF2 DRAXIN SPATA21 PRAMEF6 UBR4 SYF2 PRAMEF13 MTOR PRAMEF14 | 1.54e-03 | 681 | 253 | 11 | chr1p36 |
| GeneFamily | PRAME family | 9.09e-08 | 24 | 176 | 6 | 686 | |
| GeneFamily | ATPases Ca2+ transporting | 1.05e-06 | 9 | 176 | 4 | 1209 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 5.79e-06 | 13 | 176 | 4 | 685 | |
| GeneFamily | Dyneins, axonemal | 1.87e-05 | 17 | 176 | 4 | 536 | |
| GeneFamily | Ankyrin repeat domain containing | ACAP1 POTEE ANKRD2 TRPV2 PLA2G6 POTEF ANKEF1 ANKRD17 TNKS POTEJ POTEI | 2.59e-05 | 242 | 176 | 11 | 403 |
| GeneFamily | EF-hand domain containing | 5.84e-05 | 219 | 176 | 10 | 863 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 9.24e-04 | 5 | 176 | 2 | 1333 | |
| GeneFamily | Exostosin glycosyltransferase family | 9.24e-04 | 5 | 176 | 2 | 431 | |
| GeneFamily | SNAP complex | 9.24e-04 | 5 | 176 | 2 | 952 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.42e-04 | 206 | 176 | 8 | 682 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.92e-03 | 7 | 176 | 2 | 1113 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 1.92e-03 | 7 | 176 | 2 | 1208 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.54e-03 | 8 | 176 | 2 | 939 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 2.75e-03 | 29 | 176 | 3 | 396 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 3.24e-03 | 9 | 176 | 2 | 90 | |
| GeneFamily | UDP glucuronosyltransferases | 3.66e-03 | 32 | 176 | 3 | 363 | |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_DN | 6.62e-07 | 102 | 253 | 9 | M5601 | |
| Coexpression | GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP | TRIO ATG13 KPNA6 MOCS3 UTP20 CPLANE1 ZC3H12A FHOD1 ZNF335 DNAH17 ATP1A1 | 3.86e-06 | 198 | 253 | 11 | M4309 |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | SPTA1 RB1CC1 POTEE DST ANLN YAP1 OR5H1 KIFC1 POTEF OR5H15 OR5H14 UGT1A4 FOXD3 MLH3 OR5H8 POTEJ POTEI KIF13A ZRANB1 | 4.57e-06 | 584 | 253 | 19 | MM1080 |
| Coexpression | DESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR | 5.02e-06 | 98 | 253 | 8 | MM3656 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | PRAMEF5 PRAMEF1 PRAMEF2 TRIP12 NF1 MCM3AP PRAMEF6 TPST1 PRAMEF13 PRAMEF14 | 1.07e-05 | 180 | 253 | 10 | MM612 |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 1.78e-05 | 34 | 253 | 5 | MM955 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED | 1.83e-05 | 57 | 253 | 6 | MM1262 | |
| Coexpression | GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP | 2.54e-05 | 199 | 253 | 10 | M3599 | |
| Coexpression | GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP | 2.66e-05 | 200 | 253 | 10 | M8975 | |
| Coexpression | SANSOM_APC_TARGETS | PRAMEF5 PRAMEF1 PRAMEF2 SGF29 PRAMEF6 MTHFD1L TTC27 PRAMEF13 CEP72 PRAMEF14 NINL | 2.86e-05 | 245 | 253 | 11 | MM735 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TRIO RNF13 RB1CC1 TRIP12 CLIP1 DST SACS YAP1 BUB1B UTP20 ACBD3 NIPBL TPST1 CDC42BPA BTAF1 ATP2C1 MTIF2 ANKRD17 TNKS WDFY3 ATP2B1 VPS13B | 3.26e-05 | 856 | 253 | 22 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 4.12e-05 | 169 | 253 | 9 | M39230 | |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | 4.71e-05 | 98 | 253 | 7 | MM592 | |
| Coexpression | HUANG_GATA2_TARGETS_DN | 4.71e-05 | 98 | 253 | 7 | MM942 | |
| Coexpression | BORCZUK_MALIGNANT_MESOTHELIOMA_UP | EPRS1 RAD1 BUB1B ACBD3 MAPKAP1 MAGED1 CDC42BPA RFC4 CRABP2 CCT5 PRKDC ATP2A2 | 5.30e-05 | 310 | 253 | 12 | M10236 |
| Coexpression | HALLMARK_PEROXISOME | 6.89e-05 | 104 | 253 | 7 | M5949 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | MAP4 SERTAD2 EXT2 RB1CC1 MPRIP DST NUFIP2 COL6A3 MAGED1 CDC42BPA ATP1A1 ATP2A2 | 1.56e-09 | 197 | 253 | 12 | e77016d64b1cac9825fec7cfe5071f1567401187 |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAP4 SERTAD2 EXT2 RB1CC1 MPRIP DST NUFIP2 COL6A3 MAGED1 CDC42BPA ATP1A1 ATP2A2 | 1.56e-09 | 197 | 253 | 12 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.03e-07 | 197 | 253 | 10 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | TRIO NF1 YAP1 DIAPH2 PPP1R9A ZNF407 WDFY3 KIF13A VPS13B EXOC4 | 2.13e-07 | 198 | 253 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-07 | 199 | 253 | 10 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-06 | 194 | 253 | 9 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 194 | 253 | 9 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.76e-06 | 194 | 253 | 9 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 195 | 253 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 195 | 253 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 196 | 253 | 9 | b880c9665d42c76ea1971d4e49d7ecf72fcfafb6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.99e-06 | 197 | 253 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.48e-06 | 168 | 253 | 8 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-06 | 169 | 253 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.04e-06 | 177 | 253 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-06 | 181 | 253 | 8 | 41969fe4d94ee77b12ecde32170aaf0b13e49644 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.47e-06 | 181 | 253 | 8 | 1110a0375189c034e6b02e6ebceb7084e4590114 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-06 | 181 | 253 | 8 | 3f50e61dc2a52d71a5801584617607e6246adcf2 | |
| ToppCell | Control-Lymphocytic_NKT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-05 | 185 | 253 | 8 | 59d68e119f58b35bab36294758f6b2e25fd8f5c0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 185 | 253 | 8 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 185 | 253 | 8 | af86e75096c1812ae27a78405355957ee8043d84 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.20e-05 | 187 | 253 | 8 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.25e-05 | 188 | 253 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 189 | 253 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 189 | 253 | 8 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.35e-05 | 190 | 253 | 8 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | 11.5-Distal-Immune-Hematopoietic,_Natural_Killer_Cell|Distal / Age, Tissue, Lineage and Cell class | 1.35e-05 | 190 | 253 | 8 | caac193f12705d7cabf6f0b148f0ff267e9ffef6 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 192 | 253 | 8 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.51e-05 | 193 | 253 | 8 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 193 | 253 | 8 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 193 | 253 | 8 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | facs-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 193 | 253 | 8 | 15c86e20b97b6983410b36d308cddff56d141c98 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 194 | 253 | 8 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 194 | 253 | 8 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 194 | 253 | 8 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 196 | 253 | 8 | d74e899cc120146dded3a20716e22c7aca4f074a | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-05 | 142 | 253 | 7 | f7d0d5ca9fc3dd929d4fdd59b71bfa623007e992 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast-Mast_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-05 | 142 | 253 | 7 | 2a9a070e7c53ac593d46c6c5f6983f07d4413501 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.75e-05 | 197 | 253 | 8 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 198 | 253 | 8 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 198 | 253 | 8 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.81e-05 | 198 | 253 | 8 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.88e-05 | 199 | 253 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-05 | 200 | 253 | 8 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-05 | 200 | 253 | 8 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.95e-05 | 200 | 253 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 150 | 253 | 7 | 9cb3332924bd67c966873343c14445e30d3f384f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-05 | 155 | 253 | 7 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-05 | 155 | 253 | 7 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-05 | 160 | 253 | 7 | b2d8940ea8c068273b7da1589d3d6ae5110d8209 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-05 | 160 | 253 | 7 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-05 | 160 | 253 | 7 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-05 | 160 | 253 | 7 | 229841be7b984a00a301cd5d88c11226a90d8a88 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-05 | 160 | 253 | 7 | 99c9ae2041445539fada842e1af01368669bfca0 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-05 | 160 | 253 | 7 | 9caab1bb63c7e66c44783852ee75b16bb40fa594 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-05 | 165 | 253 | 7 | 0c80abf13409767825ef8a507b498afafa7e89c5 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-05 | 165 | 253 | 7 | cced77f2d74b07010307d7f4788b8cf3fdaeb91a | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.01e-05 | 168 | 253 | 7 | 53a982869dbf14f6a948589be9f2f3df3b9a7e97 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.81e-05 | 172 | 253 | 7 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.81e-05 | 172 | 253 | 7 | c477008444d2d71071177807870d7455e90c2fad | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-05 | 175 | 253 | 7 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.48e-05 | 175 | 253 | 7 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-05 | 176 | 253 | 7 | b942227abf9902ba13fac6c3e9efb0cacc82af94 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 6.72e-05 | 176 | 253 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.96e-05 | 177 | 253 | 7 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 6.96e-05 | 177 | 253 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 178 | 253 | 7 | e0769ad06f92423a3cb6c78a61da3ba5bd9b4eae | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 178 | 253 | 7 | 12d5c6be6cfbf733e3cb02780606b3725eda7d2b | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.21e-05 | 178 | 253 | 7 | 910f8bea19d335455aba24e6a07b4834b709db5d | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 178 | 253 | 7 | 11c2ce093b7538518c8d4497dc5b0b4da22bf1a8 | |
| ToppCell | Control-Lymphocytic_NKT-T_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.47e-05 | 179 | 253 | 7 | d892d9496f1c33e23312092591eb2e968e736f7d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.47e-05 | 179 | 253 | 7 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.74e-05 | 180 | 253 | 7 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.74e-05 | 180 | 253 | 7 | bb2dbf7ed03d5ac765635b7afe738efa822841d0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.74e-05 | 180 | 253 | 7 | c62417f205bcbf3b212ae177f63562ec6467c855 | |
| ToppCell | NS-moderate-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.01e-05 | 181 | 253 | 7 | 7fb3c1d29c542a3cea7fa654432d501d82df138f | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.29e-05 | 182 | 253 | 7 | 111d434b89902ec11fb07f41b8ee1a98f3991b61 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 184 | 253 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 184 | 253 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 184 | 253 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-05 | 185 | 253 | 7 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.50e-05 | 186 | 253 | 7 | 7b67e588b3c95074367b2cf20d2fc72d1385ee28 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 9.82e-05 | 187 | 253 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 9.82e-05 | 187 | 253 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.82e-05 | 187 | 253 | 7 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 9.82e-05 | 187 | 253 | 7 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 188 | 253 | 7 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 188 | 253 | 7 | 6b185d0aaeea64f9ae584a9bcb9741658bb1c7bd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-04 | 189 | 253 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 189 | 253 | 7 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 190 | 253 | 7 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.08e-04 | 190 | 253 | 7 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 190 | 253 | 7 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 190 | 253 | 7 | b772a5d281fe016f259ddda80d6f33d949dcac2b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 190 | 253 | 7 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 1.08e-04 | 190 | 253 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 190 | 253 | 7 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 253 | 7 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 191 | 253 | 7 | 96a7179a845d3daa046ed71fa45c51255f130a7f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-04 | 191 | 253 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| Drug | AC1L1G0K | 5.78e-08 | 49 | 250 | 8 | CID000003473 | |
| Drug | lanthanum chloride hydrate | 1.42e-07 | 23 | 250 | 6 | CID000165791 | |
| Drug | TBHQ | CYP1A1 NF1 UGT1A5 ABCC5 UGT1A4 UGT1A3 NFE2L3 ATP2C1 ATP2A2 ATP2A3 ATP2B1 | 4.70e-07 | 141 | 250 | 11 | CID000016043 |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | TRIO STAT5B ZBTB7A MCM3AP DIAPH2 UTP20 ABCD1 SLC5A3 CCDC88C LINS1 CEP72 ANKEF1 | 1.61e-06 | 193 | 250 | 12 | 1022_DN |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | MED18 CLIP1 ZBTB7A NF1 KITLG MOCS3 TLN2 SEMA6A LIG3 WDFY3 CABIN1 VPS13B | 1.89e-06 | 196 | 250 | 12 | 5425_DN |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A | MED18 MAP4 NCLN STAT5B PLA2G6 ABCD1 PLXNB1 TPST1 CCDC88C SNAPC2 CABIN1 KIF13A | 1.89e-06 | 196 | 250 | 12 | 4779_DN |
| Drug | Ald1.1-H_000455; Down 200; 10uM; MCF7; HT_HG-U133A | CYP1A1 MED18 MAP4 UBN1 SEMA6A MGA ACBD3 CDC42BPA ATP2C1 ANKEF1 IRAK3 SNAPC2 | 2.10e-06 | 198 | 250 | 12 | 7542_DN |
| Drug | 1sqc | 2.83e-06 | 10 | 250 | 4 | CID000444279 | |
| Drug | 2,5-dimethylquinone | 4.41e-06 | 11 | 250 | 4 | CID000008718 | |
| Drug | 1vyq | 6.56e-06 | 12 | 250 | 4 | CID004369390 | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; PC3; HT_HG-U133A | GADD45B TRIO MAP4 URB1 NF1 TLN2 ZC3H12A CCDC88C ABCG1 KLHL25 ZNF335 | 1.06e-05 | 194 | 250 | 11 | 5091_UP |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | ATP5F1D GADD45B MAP4 NF1 TPST1 CDC42BPA GRB10 LIG3 ABCG1 MLH3 MTOR | 1.16e-05 | 196 | 250 | 11 | 3416_DN |
| Drug | p-hydroxyhippuric acid | 1.30e-05 | 14 | 250 | 4 | CID000151012 | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | TBC1D19 TLN2 CDC42BPA CEP162 FBXO46 LIG3 ATP2C1 IPO9 NECAB3 WDFY3 SNAPC2 | 1.41e-05 | 200 | 250 | 11 | 3465_DN |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.76e-05 | 15 | 250 | 4 | CID000040469 | |
| Drug | E1-P | 2.83e-05 | 33 | 250 | 5 | CID000104406 | |
| Drug | BP-3,6-quinol | 2.83e-05 | 33 | 250 | 5 | CID000119292 | |
| Drug | triclocarban | 3.02e-05 | 17 | 250 | 4 | ctd:C009540 | |
| Drug | AC1L88YH | 3.02e-05 | 17 | 250 | 4 | CID000374551 | |
| Drug | thryroxine | TPO CYP1A1 MC3R CLIP1 DUOX1 UGT1A5 PIGS UGT1A4 UGT1A3 ABCG1 THRB ATP1A1 ATP1A3 | 3.21e-05 | 302 | 250 | 13 | CID000000853 |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 3.85e-05 | 18 | 250 | 4 | CID000036614 | |
| Drug | XeC compound | 3.90e-05 | 84 | 250 | 7 | CID000005701 | |
| Drug | mag-fura-2 | 5.02e-05 | 37 | 250 | 5 | CID000123839 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | ATP5F1D ATG13 UTP20 SGF29 GRB10 LIG3 ZNF335 GEMIN4 SNAPC3 CABIN1 | 5.03e-05 | 190 | 250 | 10 | 1306_DN |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 5.49e-05 | 192 | 250 | 10 | 7427_DN | |
| Drug | Fillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | MAL NF1 KITLG PLA2G6 SEMA6A DNAH9 TMUB2 PPP1R9A ABCG1 ATP2A2 | 5.49e-05 | 192 | 250 | 10 | 2813_UP |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A | GADD45B HIP1 MAP4 ATG13 CLIP1 STAT5B NF1 MOCS3 DIAPH2 PLXNB1 | 5.73e-05 | 193 | 250 | 10 | 7409_DN |
| Drug | tectochrysin | 5.99e-05 | 20 | 250 | 4 | CID005281954 | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A | 6.25e-05 | 195 | 250 | 10 | 5878_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 6.25e-05 | 195 | 250 | 10 | 2283_DN | |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; MCF7; HT_HG-U133A | TBC1D19 TRIO SPTA1 CLIP1 MAP3K1 NF1 SLC5A3 THRB GUCY2D IL1RL1 | 6.25e-05 | 195 | 250 | 10 | 6104_UP |
| Drug | Glycopyrrolate [596-51-0]; Up 200; 10uM; MCF7; HT_HG-U133A | TBC1D19 MED18 NF1 KITLG PLXNB1 LIG3 KLHL25 IL1RL1 SNAPC2 SNAPC3 | 6.25e-05 | 195 | 250 | 10 | 3427_UP |
| Drug | Pimozide [2062-78-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | MED18 ZBTB7A NF1 MOCS3 MCM3AP CCDC88C ABCG1 IPO9 SNAPC2 KIF13A | 6.53e-05 | 196 | 250 | 10 | 3178_DN |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A | GADD45B NF1 TBC1D12 TLN2 TPST1 CDC42BPA GRB10 CDC42BPB MTOR ATP2A3 | 6.81e-05 | 197 | 250 | 10 | 7019_DN |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 6.81e-05 | 197 | 250 | 10 | 3436_DN | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; HL60; HG-U133A | EXT2 RB1CC1 DNASE1L1 DHX57 LIG3 ATP2C1 MTOR ZNF335 IRAK3 PRKDC | 6.81e-05 | 197 | 250 | 10 | 1977_UP |
| Drug | AC1MMLID | 7.01e-05 | 92 | 250 | 7 | CID000013245 | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; HL60; HG-U133A | MED18 MAP4 EXT2 NCLN ANAPC2 ZC3H12A GRB10 FBXO46 ATP2C1 GEMIN4 | 7.10e-05 | 198 | 250 | 10 | 2002_DN |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | MAP4 ATG13 GLI3 DIAPH2 GRB10 DHX57 LINS1 ZNF335 ANKEF1 MARF1 | 7.10e-05 | 198 | 250 | 10 | 5298_DN |
| Drug | Bisoprolol fumarate; Down 200; 9uM; HL60; HT_HG-U133A | PAK4 KPNA6 ITGAL ANAPC2 DNASE1L1 ZC3H12A FHOD1 GEMIN4 IRAK3 CABIN1 | 7.10e-05 | 198 | 250 | 10 | 1287_DN |
| Drug | Nimesulide [51803-78-2]; Up 200; 13uM; MCF7; HT_HG-U133A | DUOX1 NF1 KITLG ZC3H12A HAP1 DHX57 LIG3 KIF13A ATP2A2 ATP2A3 | 7.10e-05 | 198 | 250 | 10 | 7024_UP |
| Drug | Avermectin B1 [71751-41-2]; Down 200; 4.8uM; MCF7; HT_HG-U133A | MED18 GLI3 TMUB2 NR1D2 CDC42BPA SLC5A3 CCDC88C LIG3 ATP2C1 PATJ | 7.10e-05 | 198 | 250 | 10 | 7218_DN |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; MCF7; HT_HG-U133A | GADD45B MAP4 RYR2 NF1 NR1D2 HAP1 CEP162 ADAMTS5 KLHL25 WDFY3 | 7.41e-05 | 199 | 250 | 10 | 1699_UP |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 7.41e-05 | 199 | 250 | 10 | 7217_DN | |
| Drug | Meglumine [6284-40-8]; Up 200; 20.4uM; HL60; HT_HG-U133A | 7.72e-05 | 200 | 250 | 10 | 3068_UP | |
| Drug | C13932 | HIP1 RYR2 KITLG TRPV2 COL6A3 ATP2C1 MTOR ATP2A2 ATP2A3 ATP2B1 | 9.87e-05 | 206 | 250 | 10 | CID000168297 |
| Drug | AC1L1IZE | 1.02e-04 | 131 | 250 | 8 | CID000004799 | |
| Drug | AC1MRQNQ | 1.05e-04 | 9 | 250 | 3 | CID003522271 | |
| Drug | DHPASiU | 1.05e-04 | 9 | 250 | 3 | CID000197602 | |
| Drug | 3-iodophenol | 1.05e-04 | 9 | 250 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 1.05e-04 | 9 | 250 | 3 | CID000186631 | |
| Drug | Chebi:32663 | 1.05e-04 | 9 | 250 | 3 | CID005460873 | |
| Drug | AC1L25Y6 | 1.07e-04 | 23 | 250 | 4 | CID000015465 | |
| Drug | mercury | CYP1A1 TNFAIP8L3 RYR2 CDAN1 KIAA1210 ANLN HSPD1 CACNA1F EVC2 ABCC5 ABCG1 ATP2C1 MTOR ATP2A2 ATP2A3 ATP2B1 PIK3R5 | 1.12e-04 | 542 | 250 | 17 | CID000023931 |
| Drug | verapamil | CYP1A1 MYH2 KCNV2 RYR2 ABCD1 DNASE1L1 CACNA1F ABCC5 ABCG1 ATP2C1 ABCA6 ATP1A1 ATP1A3 ATP2A2 ATP2A3 ATP2B1 | 1.13e-04 | 490 | 250 | 16 | CID000002520 |
| Drug | anthraflavic acid | 1.17e-04 | 44 | 250 | 5 | CID000006776 | |
| Drug | afloqualone | 1.20e-04 | 2 | 250 | 2 | ctd:C033541 | |
| Drug | cyhexatin | 1.50e-04 | 25 | 250 | 4 | CID005364545 | |
| Drug | cocaethylene | 1.52e-04 | 73 | 250 | 6 | CID000002825 | |
| Drug | dodecyl ether | 1.75e-04 | 26 | 250 | 4 | CID000020667 | |
| Drug | 7-hydroxycoumarin | 1.76e-04 | 75 | 250 | 6 | CID005281426 | |
| Drug | 1-hydroxypyrene | 1.79e-04 | 48 | 250 | 5 | CID000021387 | |
| Drug | N-benzylformamide | 1.90e-04 | 76 | 250 | 6 | CID000080654 | |
| Drug | Sm28 | 2.02e-04 | 11 | 250 | 3 | CID000486048 | |
| Drug | 4-nitrophenyl)imidazole | 2.02e-04 | 11 | 250 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 2.02e-04 | 11 | 250 | 3 | CID006442661 | |
| Drug | R 478 | 2.02e-04 | 11 | 250 | 3 | CID000084223 | |
| Drug | ouabagenin | 2.02e-04 | 11 | 250 | 3 | CID000010497 | |
| Drug | diflunisal | 2.04e-04 | 27 | 250 | 4 | CID000003059 | |
| Drug | apigenin | CYP1A1 GADD45B TNFAIP8L3 MAP3K1 ZBTB7A UGT1A5 UGT1A4 UGT1A3 PIK3R5 | 2.07e-04 | 184 | 250 | 9 | CID005280443 |
| Drug | erythromycin stearate | 2.28e-04 | 111 | 250 | 7 | CID000012559 | |
| Drug | Fura-2AM | 2.35e-04 | 79 | 250 | 6 | CID000105091 | |
| Drug | H-Ni | 2.36e-04 | 28 | 250 | 4 | CID000445665 | |
| Drug | epicholesterol | CYB5D2 MAL ACAT1 CYP39A1 KITLG ABCD1 ALDH9A1 ACBD3 COL6A3 HAP1 ABCG1 ATP2C1 THRB ABCA6 SLC13A5 ATP2A2 ATP2A3 ATP2B1 | 2.51e-04 | 636 | 250 | 18 | CID000000304 |
| Drug | DNCB | CYP1A1 TNFAIP8L3 SPTA1 CYP39A1 UGT1A5 PIGS ABCC5 UGT1A4 UGT1A3 | 2.53e-04 | 189 | 250 | 9 | CID000000006 |
| Drug | trifluoperazine | MYH2 SPTA1 SPTBN5 PHKA1 UGT1A5 UGT1A4 UGT1A3 ATP2C1 CABIN1 ATP2A2 ATP2A3 ATP2B1 | 2.63e-04 | 324 | 250 | 12 | CID000005566 |
| Drug | Thiostrepton [1393-48-2]; Down 200; 2.4uM; MCF7; HT_HG-U133A | 2.63e-04 | 190 | 250 | 9 | 4385_DN | |
| Drug | N-OH-DABZ | 2.67e-04 | 12 | 250 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 2.67e-04 | 12 | 250 | 3 | CID000088735 | |
| Drug | 2,4,6-TCB | 2.67e-04 | 12 | 250 | 3 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 2.67e-04 | 12 | 250 | 3 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 2.67e-04 | 12 | 250 | 3 | CID000276709 | |
| Drug | kojic acid | GADD45B HIP1 ERCC5 RB1CC1 RAD1 ABCD1 HSPD1 SMC6 NOL11 SYF2 THRB CEP72 IL1RL1 EPHA10 | 2.69e-04 | 424 | 250 | 14 | ctd:C011890 |
| Drug | octaethylene glycol | 2.72e-04 | 29 | 250 | 4 | CID000078798 | |
| Drug | 7-hydroxycoumarin glucuronide | 2.72e-04 | 29 | 250 | 4 | CID000125641 | |
| Drug | 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | 2.72e-04 | 29 | 250 | 4 | ctd:C060533 | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | CYP1A1 GADD45B PLXNB1 ZC3H12A ABCG1 FHOD1 ANKEF1 GEMIN4 ATP2A3 | 2.74e-04 | 191 | 250 | 9 | 1008_DN |
| Drug | Tranilast sodium | 2.83e-04 | 115 | 250 | 7 | CID000005527 | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 2.84e-04 | 192 | 250 | 9 | 4110_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; HL60; HT_HG-U133A | 2.84e-04 | 192 | 250 | 9 | 1286_DN | |
| Drug | magnesium fluoride | 2.86e-04 | 53 | 250 | 5 | CID000024546 | |
| Drug | Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; HL60; HT_HG-U133A | 2.95e-04 | 193 | 250 | 9 | 3028_DN | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; HL60; HT_HG-U133A | 2.95e-04 | 193 | 250 | 9 | 1860_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.95e-04 | 193 | 250 | 9 | 2904_DN | |
| Drug | Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; HL60; HT_HG-U133A | 2.97e-04 | 153 | 250 | 8 | 2195_UP | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.07e-04 | 194 | 250 | 9 | 7322_DN | |
| Drug | Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 3.07e-04 | 194 | 250 | 9 | 7032_UP | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 3.07e-04 | 194 | 250 | 9 | 3194_DN | |
| Drug | quercetin | CYP1A1 TNFAIP8L3 PHKA1 ABCC8 COL6A3 UGT1A5 ECH1 UGT1A4 UGT1A3 ATP2C1 MTOR IRAK3 ATP2A2 ATP2A3 ATP2B1 | 3.08e-04 | 482 | 250 | 15 | CID005280343 |
| Drug | paricalcitol | 3.11e-04 | 30 | 250 | 4 | CID005281104 | |
| Disease | Colorectal Carcinoma | CYB5D2 ACAP1 ATP7B APC2 NF1 SACS YAP1 ABCC8 GLI3 MCM3AP BUB1B EVC2 MTHFD1L ABCC5 ADAMTSL3 LIG3 ABCG1 MLH3 ABCA6 PUS10 PIK3R5 EXOC4 | 8.22e-08 | 702 | 240 | 22 | C0009402 |
| Disease | Malignant neoplasm of breast | CYP1A1 ACAP1 MAL ATP7B RAPH1 APC2 RPS7 RB1CC1 CLIP1 MAP3K1 STAT5A NF1 YAP1 SPATA21 UTP20 DNAH9 NIPBL PLXNB1 PIGS UBR4 SMC6 RFC4 CCT5 MTOR ANKEF1 ATP2A3 VPS13B | 2.31e-07 | 1074 | 240 | 27 | C0006142 |
| Disease | p-cresol glucuronide measurement | 2.01e-06 | 12 | 240 | 4 | EFO_0800079 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 1.82e-05 | 7 | 240 | 3 | DOID:0060178 (implicated_via_orthology) | |
| Disease | X-11793--oxidized bilirubin measurement | 2.89e-05 | 8 | 240 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.89e-05 | 8 | 240 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 2.89e-05 | 8 | 240 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.89e-05 | 8 | 240 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.89e-05 | 8 | 240 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.89e-05 | 8 | 240 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.89e-05 | 8 | 240 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 2.89e-05 | 8 | 240 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.89e-05 | 8 | 240 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.89e-05 | 8 | 240 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 4.31e-05 | 9 | 240 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 4.31e-05 | 9 | 240 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 4.31e-05 | 9 | 240 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 4.31e-05 | 9 | 240 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 4.31e-05 | 9 | 240 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 4.31e-05 | 9 | 240 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 4.31e-05 | 9 | 240 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 4.31e-05 | 9 | 240 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 4.31e-05 | 9 | 240 | 3 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 6.11e-05 | 10 | 240 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 6.11e-05 | 10 | 240 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 6.11e-05 | 10 | 240 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 6.11e-05 | 10 | 240 | 3 | EFO_0800867 | |
| Disease | dystonia 12 (is_implicated_in) | 6.59e-05 | 2 | 240 | 2 | DOID:0090056 (is_implicated_in) | |
| Disease | Peripheral Vascular Diseases | 6.59e-05 | 2 | 240 | 2 | C0085096 | |
| Disease | sPARC-related modular calcium-binding protein 1 measurement | 6.59e-05 | 2 | 240 | 2 | EFO_0021868 | |
| Disease | plasma N-desmethylclozapine measurement | 8.36e-05 | 11 | 240 | 3 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 8.36e-05 | 11 | 240 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 8.36e-05 | 11 | 240 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 8.36e-05 | 11 | 240 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 8.36e-05 | 11 | 240 | 3 | EFO_0010219 | |
| Disease | xanthurenate measurement | 8.64e-05 | 29 | 240 | 4 | EFO_0010551 | |
| Disease | nervous system disease (implicated_via_orthology) | 1.11e-04 | 12 | 240 | 3 | DOID:863 (implicated_via_orthology) | |
| Disease | biliverdin measurement | 1.11e-04 | 12 | 240 | 3 | EFO_0021033 | |
| Disease | retinol dehydrogenase 16 measurement | 1.43e-04 | 13 | 240 | 3 | EFO_0802007 | |
| Disease | superior frontal gyrus grey matter volume measurement | 1.81e-04 | 14 | 240 | 3 | EFO_0006516 | |
| Disease | Brody myopathy (implicated_via_orthology) | 1.97e-04 | 3 | 240 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | blood pressure, response to thiazide, response to beta blocker | 1.97e-04 | 3 | 240 | 2 | EFO_0004325, EFO_0007766, EFO_0007981 | |
| Disease | heart disease (implicated_via_orthology) | 2.54e-04 | 38 | 240 | 4 | DOID:114 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 3.32e-04 | 17 | 240 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | congenital stationary night blindness (is_implicated_in) | 3.91e-04 | 4 | 240 | 2 | DOID:0050534 (is_implicated_in) | |
| Disease | angiopoietin-related protein 1 measurement | 3.96e-04 | 18 | 240 | 3 | EFO_0801382 | |
| Disease | lymphocyte count | MED18 ACAP1 EPPK1 RAPH1 SPTA1 EXTL2 NCLN TRIP12 ITGB7 STAT5B ZBTB7A MCM3AP PLA2G6 ABCD1 APBB1IP FRAS1 PCDHGB7 POTEF ABCC5 FIS1 NFE2L3 THRB PUS10 DNAH17 ELF1 | 3.99e-04 | 1464 | 240 | 25 | EFO_0004587 |
| Disease | Colorectal Neoplasms | 4.73e-04 | 277 | 240 | 9 | C0009404 | |
| Disease | Infiltrating duct carcinoma of female breast | 6.34e-04 | 21 | 240 | 3 | C3165106 | |
| Disease | tissue factor measurement | 6.34e-04 | 21 | 240 | 3 | EFO_0010623 | |
| Disease | non-high density lipoprotein cholesterol measurement | SPTA1 RPS7 SERTAD2 ERGIC2 NUFIP2 PLA2G6 GTPBP3 UGT1A5 SMC6 EPGN UGT1A4 UGT1A3 NFE2L3 THRB ABCA6 | 8.02e-04 | 713 | 240 | 15 | EFO_0005689 |
| Disease | health literacy measurement | 9.14e-04 | 53 | 240 | 4 | EFO_0010104 | |
| Disease | abdominal adipose tissue measurement | 9.14e-04 | 53 | 240 | 4 | EFO_0803316 | |
| Disease | gene methylation measurement | 9.67e-04 | 6 | 240 | 2 | EFO_0006959 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 9.67e-04 | 6 | 240 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | extraversion measurement | 9.67e-04 | 6 | 240 | 2 | EFO_0007913 | |
| Disease | Metastatic melanoma | 9.81e-04 | 54 | 240 | 4 | C0278883 | |
| Disease | Neurodevelopmental Disorders | 9.92e-04 | 93 | 240 | 5 | C1535926 | |
| Disease | upper respiratory tract disorder | 1.50e-03 | 28 | 240 | 3 | MONDO_0004867 | |
| Disease | cancer (implicated_via_orthology) | 1.66e-03 | 268 | 240 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | plasma clozapine measurement | 1.79e-03 | 8 | 240 | 2 | EFO_0600038 | |
| Disease | Embryonal Rhabdomyosarcoma | 1.79e-03 | 8 | 240 | 2 | C0206656 | |
| Disease | Disorder of eye | 1.82e-03 | 212 | 240 | 7 | C0015397 | |
| Disease | response to dolutegravir | 1.83e-03 | 30 | 240 | 3 | EFO_0600017 | |
| Disease | Headache | 1.85e-03 | 64 | 240 | 4 | HP_0002315 | |
| Disease | visceral adipose tissue measurement | CYP1A1 SERTAD2 TRIP12 ZBTB7A ABCD1 IPO9 CADPS MTOR SPHKAP PATJ CCDC171 | 2.08e-03 | 481 | 240 | 11 | EFO_0004765 |
| Disease | Large cell carcinoma of lung | 2.21e-03 | 32 | 240 | 3 | C0345958 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 2.28e-03 | 9 | 240 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Polydactyly | 2.73e-03 | 117 | 240 | 5 | C0152427 | |
| Disease | stomach cancer (is_implicated_in) | 2.85e-03 | 72 | 240 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Adenoma, Microcystic | 3.11e-03 | 36 | 240 | 3 | C0205648 | |
| Disease | Adenoma, Monomorphic | 3.11e-03 | 36 | 240 | 3 | C0205649 | |
| Disease | Adenoma, Basal Cell | 3.11e-03 | 36 | 240 | 3 | C0205646 | |
| Disease | Follicular adenoma | 3.11e-03 | 36 | 240 | 3 | C0205647 | |
| Disease | Papillary adenoma | 3.11e-03 | 36 | 240 | 3 | C0205650 | |
| Disease | Adenoma, Trabecular | 3.11e-03 | 36 | 240 | 3 | C0205651 | |
| Disease | Adenoma | 3.11e-03 | 36 | 240 | 3 | C0001430 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.12e-03 | 364 | 240 | 9 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 3.45e-03 | 11 | 240 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Diabetic Cardiomyopathies | 3.45e-03 | 11 | 240 | 2 | C0853897 | |
| Disease | pregnenetriol sulfate measurement | 3.45e-03 | 11 | 240 | 2 | EFO_0800586 | |
| Disease | Basal cell carcinoma | 3.45e-03 | 11 | 240 | 2 | C0007117 | |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 3.45e-03 | 11 | 240 | 2 | EFO_0007889, EFO_0009366 | |
| Disease | Long QT Syndrome | 3.45e-03 | 11 | 240 | 2 | C0023976 | |
| Disease | Intellectual Disability | 3.82e-03 | 447 | 240 | 10 | C3714756 | |
| Disease | Mammary Carcinoma, Human | CYP1A1 MAL ATP7B APC2 RPS7 RB1CC1 MAP3K1 STAT5A YAP1 CCT5 MTOR | 4.03e-03 | 525 | 240 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | CYP1A1 MAL ATP7B APC2 RPS7 RB1CC1 MAP3K1 STAT5A YAP1 CCT5 MTOR | 4.03e-03 | 525 | 240 | 11 | C1257931 |
| Disease | Night blindness, congenital stationary, type 1 | 4.12e-03 | 12 | 240 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 4.12e-03 | 12 | 240 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 4.12e-03 | 12 | 240 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 4.12e-03 | 12 | 240 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 4.12e-03 | 12 | 240 | 2 | C3711543 | |
| Disease | fructose measurement, glucose measurement, galactose measurement | 4.12e-03 | 12 | 240 | 2 | EFO_0004468, EFO_0010477, EFO_0010481 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 4.12e-03 | 12 | 240 | 2 | C1848172 | |
| Disease | alkaline phosphatase measurement | ACAP1 MAP4 RPS7 SERTAD2 ERGIC2 ZBTB7A NWD2 NF1 YAP1 GLI3 NUFIP2 PLA2G6 PLEKHH2 ABCA6 SLC13A5 ELF1 TNKS | 4.13e-03 | 1015 | 240 | 17 | EFO_0004533 |
| Disease | Mammary Neoplasms | CYP1A1 MAL ATP7B APC2 RPS7 RB1CC1 MAP3K1 STAT5A YAP1 CCT5 MTOR | 4.15e-03 | 527 | 240 | 11 | C1458155 |
| Disease | cups of coffee per day measurement | 4.21e-03 | 40 | 240 | 3 | EFO_0006782 | |
| Disease | myeloid white cell count | ACAP1 EXTL2 NCLN ITGAL ZBTB7A KITLG TBC1D12 TLN2 PLXNB1 APBB1IP TPST1 CDC42BPA ABCC5 ATP1A1 ATP1A3 ATP2A2 | 4.44e-03 | 937 | 240 | 16 | EFO_0007988 |
| Disease | Combined immunodeficiency | 4.51e-03 | 41 | 240 | 3 | C0494261 | |
| Disease | Breast Carcinoma | CYP1A1 MAL ATP7B APC2 RPS7 RB1CC1 MAP3K1 STAT5A YAP1 CCT5 MTOR | 4.83e-03 | 538 | 240 | 11 | C0678222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MSFIAAVLILNLEEA | 591 | O60347 | |
| DEVLDSAMQAFLLEI | 131 | O60507 | |
| GVTLNVLEMTSEDLE | 411 | P35503 | |
| EATVSVLGELAAEMN | 1006 | O60566 | |
| LLFNAMTALTEEAAV | 11 | Q6UW88 | |
| ANMEDLTEVITASEF | 216 | Q9Y2T4 | |
| VMSILSFDTEAEVLE | 396 | P49189 | |
| IDIGAQSMAEDLDSL | 481 | O75143 | |
| ATTNAEVLRTMELAA | 96 | Q9BY43 | |
| IETIEAAEALLNMDS | 96 | P32519 | |
| MDVELADRTLSVAVT | 646 | Q9UJX6 | |
| VVSSNMEATETDLLN | 36 | P45844 | |
| MEDVISIADNILNSA | 371 | Q5T601 | |
| SANMDVLIVLATSIA | 726 | P35670 | |
| MIAIADAVKQEAALA | 1191 | P35670 | |
| ARQVELLLVADASMA | 266 | Q9UNA0 | |
| LADEQLSSVIQDMAV | 201 | Q8NFV4 | |
| SVQLLAEEAVTLDML | 111 | P30049 | |
| DLLAAIISSMAELQD | 871 | Q6TFL3 | |
| ADVLDLAETMVASAD | 91 | Q96RQ1 | |
| TVIVVLMSASDDNEG | 1141 | Q7Z2Y8 | |
| LEQADLILAMLDASD | 326 | Q969Y2 | |
| ILFSTQSMDEADILA | 666 | Q8N139 | |
| ALMADLVADISEAEQ | 66 | Q7Z5R6 | |
| GAVLQAEEMDVALSD | 136 | Q8NB90 | |
| SVSNDIDMVSFLLDL | 56 | Q9NU02 | |
| VFSEVESQAMDALDL | 546 | Q9P1A6 | |
| METANADIVTLLRLA | 681 | Q15027 | |
| QSLVMDADDEAVLNL | 186 | Q9P209 | |
| LQGVDLLADAVAVTM | 41 | P10809 | |
| AQTLNDTLDDIMAAV | 1016 | O75179 | |
| DETGVMDNLLEALQS | 1051 | O60879 | |
| IAVASEIMAVLALTD | 606 | Q6UB35 | |
| MAAVLESLLREEVSV | 1 | Q8IWY9 | |
| AEMVLSDDNFASIVA | 731 | Q93084 | |
| NLIMDTLASLALATE | 891 | P20020 | |
| ILVDDDFQTIMSAIE | 676 | P98194 | |
| ELEDVLALDNSVMSE | 676 | Q9ULI1 | |
| VTAQLEQASLSMDEA | 156 | Q70E73 | |
| AFSELDMTSEVLQIT | 166 | O60671 | |
| NDGELILTMTADDVV | 116 | P29373 | |
| EAEVLISTLQELMAG | 166 | P04798 | |
| AVLNTEARTMAAEVL | 66 | Q969V3 | |
| MEEENATLLTEFVLT | 1 | A6NDH6 | |
| DEINLEISESVSLGM | 136 | Q9Y5F8 | |
| MDDENATLLTEFVLT | 1 | P0DN80 | |
| MAALEEEFTLSSVVL | 1 | Q9H8H0 | |
| LLTAAADAIERIMSS | 391 | P33897 | |
| QSAEDVDALLLGMAS | 376 | Q9NRD9 | |
| AAQSLDEMSQTITDL | 621 | Q8TDY2 | |
| LTLDEMDNAASDLLA | 1931 | O60840 | |
| LSLFAVDMDAALEVQ | 926 | Q9ULU8 | |
| MAAQVTLEDALSNVD | 1 | Q7L576 | |
| SSAVEALDLSMEEEV | 141 | Q5VWQ8 | |
| MEEENATLLTEFVLT | 1 | A6NHG9 | |
| LNELTMDDDTAVLVI | 696 | A5A3E0 | |
| VEMLFSDDSDLQLAT | 86 | O60684 | |
| LAEETAATISAIEAM | 761 | Q6WCQ1 | |
| SLNLEMQELAVAASL | 3881 | Q86XX4 | |
| ENVTLESLTMDADAN | 1071 | P10071 | |
| AVDMLALANAVLQAV | 331 | Q8NG48 | |
| AEASVEDSALLMQTL | 16 | Q9Y5V3 | |
| VALSSETEVALARDM | 436 | P27816 | |
| EQSDASITIDQLTMA | 96 | Q99795 | |
| LTGDNLMALAEATVA | 326 | P46199 | |
| EAALDSSELLTNMED | 2801 | Q8IWI9 | |
| AAEIANMSLDILSAV | 946 | Q02846 | |
| VAMSNLSEAVQDADL | 76 | Q8N335 | |
| LADISMLRSDSENIL | 2141 | Q03001 | |
| LTQLIDEASEGDMSI | 876 | P46020 | |
| EEQEDALNISSMSLL | 596 | Q9NQW6 | |
| ADMVLLDDNFASIVT | 761 | P54707 | |
| ADMILLDDNFASIVT | 746 | P05023 | |
| LGVSNAAMEDLLTAA | 1111 | O60318 | |
| EDMVDSEILIIQSLS | 396 | Q9C098 | |
| MDVTVSELLELFLQS | 1 | Q9P219 | |
| LETNAVLMVDDDTLI | 141 | Q9UBQ6 | |
| VAEIDQDLLTSDSML | 3826 | Q5CZC0 | |
| EVFEEIAMLVQSALD | 386 | Q9BW19 | |
| MEAVLNELVSVEDLL | 1 | Q9Y3D6 | |
| VFDVQTSDNMDAVLL | 1996 | O43157 | |
| TSDNMDAVLLVIAQT | 2001 | O43157 | |
| DVDLLSVAEMVALVE | 166 | Q6PJ61 | |
| SVAEMVALVEQRAAL | 171 | Q6PJ61 | |
| LSMVNTDDVNAIILA | 16 | Q9BQD3 | |
| ALANIADMASAVEIS | 96 | Q9UHC1 | |
| ISVASIDDQEELMAT | 321 | Q9UKX2 | |
| TDALSEDLLSIIANM | 116 | P07202 | |
| EVMLDAALALAAEIS | 251 | Q13011 | |
| INIFDEINLMSLATE | 386 | Q9Y4A8 | |
| MDNSTSVREAAVELL | 1821 | Q6KC79 | |
| LVVEESSFLTLDMLE | 1091 | P55160 | |
| EDLSLNDQMIDILSS | 356 | Q86UK5 | |
| MAAVLNAERLEVSVD | 1 | Q9H3P7 | |
| DDLSVFEMDVQSLIS | 151 | Q96RT7 | |
| MSITDVLSADDIAAA | 1 | P0CE71 | |
| ELALLDQTMLTETNA | 471 | Q3SXY7 | |
| QDTVMALLASDVALE | 396 | Q96KJ4 | |
| MDEVLNTLESTQASL | 436 | Q9Y616 | |
| SLEAVAEMTAQDLVS | 961 | Q5JZY3 | |
| LDMSARLELQSALEA | 871 | Q9Y5S2 | |
| DISDNEFIMLVATTL | 191 | Q8NGS9 | |
| LNEGAMADTADLVVL | 681 | P49916 | |
| ELVFMITDALTAIAL | 81 | Q9H490 | |
| ALEMAALLSQVEIGD | 1256 | Q8IVE3 | |
| LSEDSSNVVQLIMDA | 371 | P26010 | |
| VDIATSENLTDFLME | 106 | Q9BUE0 | |
| MEEENATLLTEFVLT | 1 | A6NKK0 | |
| LNELTMDDDTAVLVI | 696 | Q6S8J3 | |
| MSITDVLSADDIAAA | 1 | P0CE72 | |
| LILDEATAAMDTETD | 1351 | O15440 | |
| ATAAMDTETDLLIQE | 1356 | O15440 | |
| IGSLMNVTADILELD | 501 | Q3MIT2 | |
| LSATDMLVSAVESLE | 151 | Q96A65 | |
| TMEDSEAVQRATALI | 31 | Q9GZV1 | |
| MEAIVAQLASDSEEL | 491 | O95996 | |
| EMVLADDNFSTIVAA | 731 | P16615 | |
| LMALSVRAAVNDTSE | 1816 | Q9C0G6 | |
| QVLDAAMEESSTSLA | 171 | Q8NBI3 | |
| SELDMLQAEALQDSL | 486 | Q01638 | |
| AAAAAASLQVLEMES | 11 | Q9NVR0 | |
| LQEAVSSEALLMADE | 246 | Q9H0H3 | |
| MIRIAALNASSTIED | 1 | Q9Y6J0 | |
| DIMVLQEVVDSSGSA | 51 | P49184 | |
| LQVFETAAASMDSEL | 1086 | O14981 | |
| QMTGLTDIADIIDDL | 2841 | Q9H799 | |
| AIEDMVASVEDQGLS | 3176 | Q9H799 | |
| MSEETTLADLLQLNL | 1376 | Q9UFH2 | |
| MQTVTAAVEELLVAA | 16 | O75293 | |
| VILMSATLNAELFSD | 696 | Q6P158 | |
| FSEASQQMAELSEVL | 356 | P54257 | |
| VDIDMAFILDSAETT | 2616 | P12111 | |
| LMSEDLTGEQALAVL | 331 | Q53R41 | |
| MLANVVLLDSLDSVA | 236 | Q5TB80 | |
| SASVLEALATITMQD | 101 | P21145 | |
| LSLLSAETMSVLQDA | 876 | Q9Y4F3 | |
| AVADMLVSVSNALET | 81 | P41968 | |
| ADMILLDDNFASIVT | 736 | P13637 | |
| LAAQFSSEVLNLVME | 571 | Q96P70 | |
| DLEALVNDMNASLES | 51 | Q13322 | |
| MAESLSEISDSLDVL | 141 | Q9ULL0 | |
| EEAILSVAAEAQVFM | 681 | Q9ULL0 | |
| DNSMTLLQATLDIVE | 241 | Q9NYL5 | |
| LNTVFLMTDAQVADE | 2876 | Q9NYC9 | |
| SDTSDEIMDLLVQSV | 1101 | Q9Y613 | |
| QVSLLFEVEDLAMAS | 2201 | Q9P225 | |
| AVLTLEDTDVANGVM | 151 | Q9BRL7 | |
| IVEAILQQMEATSAA | 151 | Q86YT5 | |
| VIDSSDEATIRLANM | 966 | Q9NZJ4 | |
| TIFEMQLAAQISESD | 4196 | Q92736 | |
| AAVDLSLELRAEVAM | 31 | Q8N4L8 | |
| MASREEVLALQAEVA | 1 | O95396 | |
| GTLVAMLTAIDADLE | 466 | O75309 | |
| DVDMSLSLLQEISSL | 541 | P30622 | |
| DMSGQTVLTAEDVDI | 11 | Q9UJU5 | |
| SLLRDQALSISAMEE | 16 | Q5VWM6 | |
| ALTLLLDEFENMSVT | 81 | O96013 | |
| AEVTQTLLNLAEFME | 1351 | P42345 | |
| LQLSDEEMSLFTAVV | 496 | Q14995 | |
| QAMSLTEDVLAAALA | 191 | Q96S52 | |
| SQLAVTSFEDIESLM | 186 | Q9H1H9 | |
| TELNSSIEDLLEASM | 1126 | Q13233 | |
| DNVVTSELLAVMDGD | 456 | Q9P2B2 | |
| MNLNEDISSLSTEEL | 231 | Q96C34 | |
| MAAEALAAEAVASRL | 1 | A2RTX5 | |
| DATASIVMDIVDDLL | 1246 | O75691 | |
| IVILDEADSMTSAAQ | 146 | P35249 | |
| ITDFAEELADTVVSM | 926 | Q2M3C7 | |
| FATMEEAAEEVLQIL | 1176 | P07814 | |
| MEDLLQALVVVSLSS | 541 | P0C7P3 | |
| SGISQALLELEMNSD | 21 | P62081 | |
| MAAIAASEVLVDSAE | 1 | O95926 | |
| QAFLELATEEAAITM | 96 | Q9UKA9 | |
| TLAQVEDALMSADVN | 256 | Q7Z572 | |
| AAVAVLDAMVESLDN | 866 | Q6ZUX3 | |
| SMILALSDTEQRLEA | 366 | Q96ER9 | |
| SLLRDQALSISAMEE | 16 | Q5SWL7 | |
| AEISFVDSLQDLMQV | 261 | Q96I59 | |
| LVSVVALALNTVEEM | 271 | Q8TDN2 | |
| LAMQAALLGSSSEEE | 346 | P28715 | |
| LALLEAQAATGTIMD | 961 | P58107 | |
| SAAIETATARIEEML | 791 | O00291 | |
| ALQLNELTMDDDTAV | 656 | P0CG39 | |
| SDDLISMGSNDIEVL | 126 | O43567 | |
| LLEEVTQGDMSAADT | 431 | Q8IY81 | |
| DSQIDIATVQDMLSS | 366 | Q9BPZ7 | |
| MRAVLDTADIAIVAL | 1 | P53794 | |
| AEIAVNAVLTVADME | 186 | P48643 | |
| SEMVVQLSDSLTDLL | 71 | P21583 | |
| EMLAEVNATITDIIS | 311 | P51692 | |
| DTSAELMCAEAILDI | 476 | Q5T8A7 | |
| SLLRDQALSISAMEE | 16 | O95521 | |
| LNELTMDDDTAVLVI | 696 | P0CG38 | |
| LNDGAAALVLMTADA | 286 | P24752 | |
| TDIMLDEVSDTVLVN | 766 | O60733 | |
| LADVAVGAESQMIVL | 596 | P20701 | |
| SLLRDQALSISAMEE | 16 | O60811 | |
| SADMIEEGELILSVN | 171 | Q92966 | |
| LVDDVSDLSAAEMLT | 101 | Q8WUJ1 | |
| ELMTVDSAVQQAALA | 366 | Q9Y2I6 | |
| MSARLELQSALDAEI | 876 | Q5VT25 | |
| DMSITELVDFILALV | 191 | O95007 | |
| MESILDETVNSVLLF | 401 | O60518 | |
| DMESVASLELANDQT | 991 | O60287 | |
| DMQAVLSLLQEVEAA | 531 | Q9NRC6 | |
| EMLAEVNATITDIIS | 311 | P42229 | |
| EATASIDMATENILQ | 1506 | Q09428 | |
| DIQLVADSALVRMSF | 461 | Q8IXR9 | |
| SLLRDQALAMSTLEE | 16 | Q5VXH4 | |
| MILEEQLLESDGSDS | 1121 | A0JNW5 | |
| SLLDALTTDMVQAIN | 326 | Q9H4F8 | |
| MDADSDVALDILITN | 1 | P62380 | |
| TVANMLIDDTSSEIF | 131 | Q5GJ75 | |
| QELAAEEASALELQM | 36 | Q5D1E8 | |
| AAAILGLVAMASDVE | 1411 | Q8IZQ1 | |
| ELLSEMAAAVQESAR | 11 | Q19AV6 | |
| DSVLQDMSLTSAAVE | 451 | Q7Z417 | |
| LDSSMEALTLNLTEV | 766 | Q8WYR1 | |
| DLESLQTAEQSLMDL | 251 | Q9P246 | |
| LTLDDILFADIDTSM | 241 | Q14140 | |
| VMVATLDTQIADDAE | 541 | Q8NI35 | |
| MALVSADSRIAELLT | 1 | Q96ES7 | |
| SEVAQMALEDQAATL | 836 | Q9H2E6 | |
| IFETEQITLDVLADM | 1046 | O95271 | |
| DDTEVALLQAVLLMS | 366 | P10828 | |
| TEAVLAIDDDIIMLT | 531 | Q93063 | |
| SLLRDQALAMSTLEE | 16 | Q5TYX0 | |
| ALVMISDNSAENIAL | 251 | Q9Y5S1 | |
| LIALMSETVNSVATD | 641 | Q9Y5S1 | |
| EALSSDILNDMESVL | 476 | P46937 | |
| DILNDMESVLAATKL | 481 | P46937 | |
| GVTLNVLEMTSEDLE | 411 | P35504 | |
| AEELFLSVEDMLVQS | 836 | Q6P2S7 | |
| RDLDQASMEAVVSLL | 1066 | P21359 | |
| SLETVTEALLEIMEA | 2201 | P21359 | |
| LEIDNAVVANSLIDM | 591 | Q96SB8 | |
| ASSQAMELSDVTLIE | 16 | Q71RG4 | |
| SVLDLQEVTLAEDFM | 341 | Q9H777 | |
| MVSSQELAEDLTGIE | 1311 | P02549 | |
| VDAEEAQRMTTLLSA | 86 | A6NLC8 | |
| ELQVSDMSFLSELTV | 66 | Q9Y2C9 | |
| DLAVLELMQSSVDNT | 1576 | P78527 | |
| AVDLGELDSLVASIM | 171 | Q5TEC3 | |
| LLQAATAMDSLTDLD | 301 | Q9NPG3 | |
| MVSELEDLSASIDVQ | 1351 | Q7Z7G8 | |
| EAVDDIMVTLNEAAS | 1806 | Q9Y4G6 | |
| DVMLENLALLTSLDV | 41 | Q13106 | |
| SVEETAAATLQTLAM | 1881 | Q9C0G0 | |
| RELADDITAMDTLVT | 816 | Q6P3X3 | |
| DITAMDTLVTELQDL | 821 | Q6P3X3 | |
| IDVAEQALTALEMLS | 536 | Q14669 | |
| DDETMVELAIALSLQ | 2811 | Q5T4S7 | |
| NLMEVTSLAAAEAVL | 491 | Q8N5T2 | |
| ESTAMATQTALDLLL | 786 | Q9H4Z2 | |
| SAAESAVVLDLLMSL | 226 | Q13487 | |
| DMLAILLTEVSQQAA | 326 | Q9UGI0 | |
| EIDFVSAEALTALMD | 76 | O95365 | |
| ASLDTSELERAVEVM | 2121 | O75962 | |
| LTLENDLIVESMSDD | 221 | Q8N402 | |
| GVTLNVLEMTSEDLE | 411 | P22310 | |
| LMETGEVSDDLASQL | 1106 | P82987 | |
| ANLADMLTVFALTED | 241 | P57678 | |
| NRALEDITASIAMAV | 396 | P57678 | |
| MDEVSLLSELVEAAS | 96 | Q9P2K6 | |
| MAATVIIAARSSEED | 156 | Q15049 | |
| SVMDTLAVALRVAEE | 186 | Q8NFW9 | |
| QSLALSSDESLDMID | 951 | Q9ULJ8 | |
| AALESLNRAVLAAMD | 111 | Q96P71 |